Document:

Exhibit 10.10

 

EMPLOYMENT AGREEMENT

 

This EMPLOYMENT AGREEMENT
(this “Agreement”) is made and entered into as of August 7, 2020, by and between CuriosityStream Inc.,
a Delaware corporation (the “Company”), and Clint Stinchcomb (“Executive”).

 

WITNESSETH:

 

WHEREAS, immediately
prior to this Agreement, Executive provided his services and expertise to the Company as its Chief Executive Officer and President;
and

 

WHEREAS, in connection
with the consummation of the transactions contemplated by that certain Merger Agreement (the “Merger Agreement”),
dated as of August 10, 2020, among the Company, HENDRICKS FACTUAL MEDIA LLC, a Delaware limited liability company, Software Acquisition
Group, Inc. , a Delaware corporation (“Parent”), and CS MERGER SUB, INC., a Delaware corporation and
a wholly-owned subsidiary of Parent, the Company desires to employ Executive, and Executive desires to be employed, on the terms
and conditions set forth in this Agreement; and

 

WHEREAS, Executive
will be receiving substantial consideration in connection with the consummation of the transactions contemplated by the Merger
Agreement, and the Company would not have entered into this Agreement without Executive’s agreement to abide by the terms
and conditions set forth herein, including, but not limited to, the restrictive covenants; and

 

WHEREAS, this Agreement
is effective as of the Closing Date, as defined in the Merger Agreement (the “Effective Date”); and

 

NOW, THEREFORE, in
consideration of the premises and the mutual covenants and agreements contained herein, and other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:

 

1. TERM OF AGREEMENT.

 

a) Executive’s
employment with the Company pursuant to this Agreement will commence on the Effective Date and end on the fourth (4th)
anniversary of the Effective Date (the “Initial Term”); provided, however, that on such
fourth (4th) anniversary of the Effective Date (the “Extension Date”), the term of Executive’s
employment under this Agreement shall be automatically extended for an additional one (1) year period (the “Renewal
Term”), unless the Company or Executive provides the other at least one hundred and eighty (180) days’ prior
written notice before the Extension Date that the Initial Term shall not be so extended, or unless terminated sooner in accordance
with the terms and conditions in Section 5 of this Agreement. The period of time from the Effective Date through the termination
of this Agreement and Executive’s employment hereunder pursuant to its terms is hereafter referred to as the “Term.”

 

     

     

    

 

b) Notwithstanding
anything herein to the contrary, this Agreement shall automatically terminate without any action on the part of any person and
be void ab initio if the Merger Agreement is terminated in accordance with its terms, and neither the Company nor any other
person shall have any liability to Executive under this Agreement if the Closing (as defined in the Merger Agreement) does not
occur.

 

c) By Executive’s
execution below, Executive acknowledges that (i) Executive’s employment with the Company may be terminated by the Company
at any time, with or without notice and for Cause (as defined below) or any other reason or no reason (subject to the provisions
of this Agreement) and (ii) except for this Agreement, there is no arrangement or agreement between Executive and the Company concerning
the terms of Executive’s employment with the Company and that nothing in this Agreement guarantees employment for any definitive
or specific term or duration or any particular level of benefits or compensation except as specifically provided for herein.

 

2. DUTIES AND PERFORMANCE. During
the Term, Executive shall be employed by the Company on a full-time basis as its Chief Executive Officer and shall have such authority
and responsibilities and shall perform such duties as are consistent with Executive’s position and otherwise consistent with
Employee’s position as may be determined from time to time by the Board of Directors of Parent (the “Board”),
including duties with respect to Affiliates of the Company, which duties shall include serving as the Chief Executive Officer of
Parent. For purposes of this Agreement, “Affiliate” means an entity controlled by, controlling or under
common control with the entity in question, and, in the case of the Company, shall include Parent but not any stockholder of Parent.
Executive shall use all reasonable efforts to further the interests of the Company and shall devote substantially all of Executive’s
business time, effort and attention to Executive’s duties hereunder. Executive shall report to the Board.

 

3. BASE SALARY AND INCENTIVE COMPENSATION.

 

a) Base
Salary. During the Term, the Company shall pay Executive a gross base salary (the “Base Salary”)
at an annualized rate of Four Hundred and Ninety Thousand Dollars ($490,000) per year, provided that the Base Salary shall be subject
to good faith review and increase (but not decrease) annually, and shall be increased by at least five percent (5%) on each anniversary
of the Effective Date. Further, if the Company’s revenue for the year ended December 31, 2020 is Thirty-Nine Million Five
Hundred Thousand Dollars ($39,500,000) or more, then effective as of January 1, 2021, the Base Salary shall increase to Five Hundred
Ninety Thousand Dollars ($590,000), and if the Company’s revenue for the year ended December 31, 2021 is Seventy-Five Million
Dollars ($75,000,000) or more, then, effective as of January 1, 2022, the Base Salary shall increase to Six Hundred Ninety Thousand
Dollars ($690,000), and if the Company’s revenue for the year ended December 31, 2022 is One Hundred Forty Million Dollars
($140,000,000) or more, then, effective as of January 1, 2023, the Base Salary shall increase to Seven Hundred Ninety Thousand
Dollars ($790,000). Base Salary payments shall be subject to deductions required by law and otherwise authorized by Executive for
his participation in employee benefit plans, and shall be payable in installments in accordance with Company’s customary
payroll practices, but in any event no less frequently than once per month. For the purposes of this Agreement, “revenue”
shall mean the Company’s total revenue, calculated in accordance with the Company’s customary accounting practices,
consistently applied.

 

    2

     

    

 

b) Annual Bonuses.
For each calendar year of the Term, Executive shall be eligible to receive an annual bonus (the “Bonus”)
based on a formula and performance criteria approved by, and the achievement of which is determined by, the Compensation Committee
of the Board (the “Committee”); provided, however, that the targeted level of the Bonus
shall be equal to One Hundred Percent (100%) of the Base Salary earned by Executive during such calendar year. Except as set forth
in Section 5, to be eligible to receive the Bonus, Executive must remain employed by the Company as of December 31st of the performance
year, and subject to the Committee’s authority under the Company’s Compensation Committee Charter, the Company must
have achieved the performance targets described in Attachment A hereto during such year; provided, however, that
if the performance targets for any year after 2021 are not achieved, or the business plan underlying the performance targets for
any year after 2020 is changed in a way that materially impacts Executive’s ability to achieve the performance targets, the
Committee shall discuss in good faith with Executive whether a full or partial Bonus is warranted; provided, further,
that for the last year of Executive’s employment hereunder, the Bonus shall be owed regardless of Executive’s separation
date unless Executive has been terminated for Cause or resigned without Good Reason (as defined in Section 5, below). The revenue
target for the year ended December 31, 2020 shall be Thirty-Six Million Dollars ($36,000,000), the revenue target for the year
ended December 31, 2021 shall be Seventy-One Million Dollars ($71,000,000), and the revenue target for the year ended December
31, 2022 shall be One Hundred Thirty-Six Million Dollars ($136,000,000). The performance criteria for each other year of the Term
shall be established by the Committee following consultation with Executive, and confirmed in writing no more than seventy-five
(75) days into the relevant performance year. The Bonus shall be paid (i) pursuant to the terms and conditions of the Company’s
bonus plan or policy then in existence for senior executives, and (ii) notwithstanding the foregoing to the contrary, but
subject to any deferral election offered to, and properly made by, Executive in respect of such Bonus, in the calendar year immediately
following the performance year for which the Bonus is owed, and shall be paid no more than thirty (30) days following the completed
financial audit of the Company’s performance for the performance year. Notwithstanding any other provisions in this Agreement
to the contrary, any Bonus (and any other incentive-based or equity-based compensation) paid to Executive pursuant to this Agreement
or any other agreement or arrangement with the Company which is subject to recovery under any law, government regulation, or stock
exchange listing requirement, will be subject to such deductions and clawback as may be required, but only to the extent required,
to be made pursuant to such law, government regulation, or stock exchange listing requirement (or any policy adopted by the Company
pursuant to and to the extent consistent with any such law, government regulation or stock exchange listing).

 

c) Special One-Time
Bonus: Upon the closure of any transaction resulting in a Change in Control of the Company at a Company valuation of $1 billion
or more, at any time prior to the third anniversary of the Effective Date (collectively, the “CIC Bonus Terms”),
Executive shall receive a bonus equal to Two Million Dollars ($2,000,000). Such bonus, if any, will not be deemed “earned”
until the date upon which the transaction resulting in the Change in Control in accordance with the CIC Bonus Terms is closed,
and provided that Executive is still employed by the Company as of such time or if Executive is terminated without Cause or for
Good Reason within the six (6) month period prior to such Change in Control, and shall be paid no later than the first regularly
scheduled payroll date that follows closure of the transaction. For purposes of this Section 3(c), “Change in Control”
shall mean the first to occur of a “change in the ownership of a corporation”, or a “change in the ownership
of a substantial portion of the assets of a corporation,” as such terms are defined in Treas. Reg. Section 1.409A-3(i)(5)(v)
and (vii).

 

    3

     

    

 

d) Equity. As
soon as practicable following the Effective Date, the Company shall use reasonable efforts to cause the Board or Committee, as
the case may be, to grant Executive options to purchase common stock of Parent (“Stock Options”), restricted
stock units in Parent, or a combination thereof, or other equity-based awards (collectively, “Equity Awards”).
The parties currently anticipate that the Equity Awards would, when taken together with the stock options then held by Executive
and equity awards otherwise granted to Executive in connection with the transactions contemplated under the Merger Agreement, entitle
Executive to no less than 5.9% of the Parent’s common stock, calculated on a fully diluted basis, on the Closing Date (as
defined in the Merger Agreement). Any grant of Stock Options as contemplated under this Section 3(d) shall be granted with an exercise
price equal to the fair market value on the grant date of a share of the common stock of Parent into which each such Stock Option
is exercisable, and otherwise generally on the same terms applicable to the existing stock options held by Executive exercisable
for shares of the Company’s common stock. All Equity Awards shall be governed by the terms of the Omnibus Incentive Plan
as defined in the Merger Agreement and approved by the shareholders of Parent; provided, however, that notwithstanding
anything to the contrary in the Plan or any grant agreement, if Executive is terminated without Cause, or resigns for Good Reason
(in each case as defined in Section 5, below), or dies or becomes disabled (as described in Section 5(a)(ii), below), all unvested
Equity Awards shall accelerate and become exercisable immediately upon such occurrence.

 

4. BENEFITS; EXPENSE
REIMBURSEMENT.

 

a) Benefits.
Executive shall receive, and have the right to participate in, such benefits as generally may be made available to all other full-time
employees of the Company from time to time, including any medical, dental, disability, life insurance, and/or savings plans, subject
to the terms and conditions of the applicable plans, and any other benefits, plans, or programs provided to other executives of
the Company at the same or a substantially similar level as Executive.

 

b) Expenses.
Executive shall also be entitled to be reimbursed in accordance with the policies of the Company, as adopted and amended from time
to time, for all reasonable and necessary business expenses actually incurred by Executive in connection with the performance of
Executive’s duties hereunder; provided that Executive shall, as a condition of such reimbursement, submit verification
of the nature and amount of such expenses in accordance with the reimbursement policies of the Company. Payment of such reimbursements
shall be made in accordance with Company policy and practice.

 

c) Miscellaneous
Reimbursements. No more than thirty (30) days following the execution of this Agreement by both parties, Executive shall submit
a request for reimbursement of attorneys’ fees incurred by Executive in connection with the negotiation and drafting of this
Agreement and any related agreements, and such amount capped at $20,000 shall be reimbursed no more than fourteen (14) days after
Executive’s submission of such request.

 

    4

     

    

 

5. TERMINATION OF AGREEMENT.

 

a) Termination
by the Company. The Company may terminate this Agreement prior to expiration of the Term and Executive’s employment with
the Company hereunder under any of the following circumstances:

 

i. with or without Cause.
For purposes of this Agreement, “Cause” shall mean the occurrence of any of the following: (A) commission
of any crime or act of theft, fraud, embezzlement, moral turpitude or similar conduct, (B) material malfeasance in the conduct
of Executive’s duties, including, (1) willful and material misuse or diversion of the Company’s (or any of its Affiliate’s)
funds or property, (2) embezzlement, and/or (3) fraudulent or willful and material misrepresentations or concealments on any written
reports submitted to the Company or its Affiliates, (C) willful violation of any material policy of the Company or Parent as in
effect from time to time (including, without limitation, policies governing discrimination or harassment); (D) illegal possession
of a controlled substance, use of illegal drugs, repetitive abuse of alcohol, or other behavior that materially interferes with
the performance of Executive’s duties to the Company or its Affiliates or that materially compromises the integrity and reputation
of Executive or the Company or its Affiliates; (E)  material breach of any noncompetition or nonsolicitation agreement to
which Executive is a party with the Company or any of its Affiliates; (F) Executive’s failure to obey the lawful orders of
the Board that fall within Executive’s scope of responsibility, and/or (G) a material breach by Executive of the provisions
of this Agreement; provided, however, that in the case of the foregoing clauses (C), (E), (F) and (G),
Executive shall have been informed, in writing, of such failure referred to in the foregoing clauses, and provided with 30 days
to cure such failure before any termination for Cause. If Executive cures the Cause event during such period, then Cause shall
be deemed to have not occurred;

 

ii. if, for any reason,
Executive suffers a Disability. For purpose of this Agreement, “Disability” shall mean the incapacity
of Executive due to physical or mental illness such that Executive is unable to perform the essential functions of Executive’s
role with or without reasonable accommodation for a period of six months in any twelve-month period and such incapacity has been
determined to exist by either (i) the Company’s disability insurance carrier or (ii) by one or more physicians as selected
by the process set forth below. If Executive is not covered by the Company’s disability insurance policy, the determination
as to Executive’s disability shall be made by a physician mutually agreeable to both Executive and the Company. If they are
unable to agree on a physician, the determination shall be made by two physicians, one selected by each of Executive and the Company,
and if such determinations are different, such physicians shall select a third physician to make the determination and his or her
determination shall be binding; or

 

b) Termination by
Reason of Death. The Term and Executive’s employment by the Company shall terminate upon the death of Executive.

 

c) Termination by
Executive. Executive may terminate this Agreement prior to the expiration of the Term, and his employment with the Company
shall terminate hereunder by notice to the Company: (i) for Good Reason; or (ii) for any other reason upon thirty (30) days’
prior written notice to the Company (the Company may pay Executive in lieu of such notice). For purposes of this Agreement, “Good
Reason” shall mean, without Executive’s consent, (i) a material diminution in Executive’s duties or position,
(ii) Executive’s Base Salary or annual target Bonus opportunity is reduced below the amounts specified herein (except for
across-the-board reductions applicable to senior executives of the Company generally); or (iii) a material breach of this Agreement
by the Company; provided, however, that it shall be a prerequisite of any such termination for Good
Reason that Executive shall have given the Company written notice within thirty (30) days following the event or events giving
rise to Good Reason, specifying in reasonable detail the nature and circumstances of such Good Reason, and given the Company thirty
(30) days to cure any such Good Reason prior to any such termination (the “Good Reason Cure Period”).
If the Company fails to remedy the condition constituting Good Reason during the Good Reason Cure Period, Executive’s termination
of employment shall occur upon expiration of such Good Reason Cure Period. If the Company cures the Good Reason event during the
Good Reason Cure Period, then Good Reason shall be deemed to have not occurred.

 

    5

     

    

 

d) Payments Due
Upon Separation. In the event of the termination of Executive’s employment prior to expiration of the Term:

 

i. for Cause, then as
of the date of such termination all of the Company’s obligations hereunder, including, without limitation, the Company’s
obligations to pay Executive’s Base Salary accruing after the date of such termination, and any benefits (except as otherwise
required by applicable law), other than those obligations that have accrued but remain unpaid as of the date of such termination
(for example to the extent required by law or Company policy, unpaid salary, expense reimbursements, health insurance premiums,
retirement plan contributions, vacation pay, etc.) (“Accrued Obligations”) shall cease, and Executive
shall not be entitled to any Bonus compensation not paid to Executive prior to such date of termination of employment.

 

ii. by reason of Executive’s
death or Disability, then the Company shall pay the Accrued Obligations, plus the portion of the Bonus due for the year of separation,
if any, from the start of the year through the date of termination of employment, based on actual performance achieved for such
year (as determined by the Committee), and payable at the same time such payment would have been made if Executive continued to
be employed by the Company (a “Prorated Bonus”).

 

iii. by Executive without
Good Reason, then all of the Company’s payment obligations hereunder, except for the Accrued Obligations, shall cease.

 

iv. by the Company without
Cause and not due to Executive’s Disability, or by Executive for Good Reason, then the Company shall pay the Accrued Obligations
and, in addition, but subject to Section 5(e) and Section 9, and provided Executive complies with the restrictive covenants set
forth herein, the Company shall (1) continue to pay Executive’s Base Salary for the balance of the Term, but in no event
in less than eighteen (18) months or in excess of thirty-six (36) months, at the rate in effect at the time of termination (but
without giving effect to any reduction that results in Good Reason) (without offset for any compensation received by Executive
from any subsequent employment by any person) in accordance with the normal payroll practices of the Company; (2) provided Executive
elects continuation of coverage as permitted under Section 4980B of the Code and the regulations thereunder (“COBRA”)
provide for the continuation of any Company health insurance benefits in which Executive and dependent members of Executive’s
immediate family participated on the date Executive’s employment with the Company terminated at the same rate as made available
to similarly situated senior executives of the Company for similar benefits, for the remainder of the Term, but only so long as
Executive (or his dependents) remain on such COBRA coverage; and (3) Bonus(es) to which Executive would have been entitled over
the remainder of the then Initial Term or then Renewal Term, as may be in effect in the year in which Executive’s termination
of employment occurs, based on actual performance achieved during the relevant performance periods and with a target of 100% of
Executive’s Base Salary earned during the year of termination, payable at the times such Bonuses would have otherwise been
payable had separation not occurred (collectively, the “Severance Benefits”).

 

    6

     

    

 

e) Release.
Notwithstanding any other provision of this Agreement, the Severance Benefits shall not be payable unless and until Executive executes
a general release of claims in the form provided by the Company and reasonably satisfactory to Executive. Executive must sign and
return the release, if at all, so that the release is effective (taking into account any revocation period provided for therein,
if any) by no later than the sixtieth (60th) calendar day following the date Executive’s employment is terminated. Subject
to Section 9, the first payment of Severance Benefits will be made on the Company’s next regular payday which is at least
five (5) business days following the expiration of the revocation period of the release; provided that, where the revocation
period of the release could result in such payday occurring in one of two calendar years, depending upon when Executive executes
the release, the first payment of Severance Benefits shall be made on the later of such payday or the first regular payday of the
second of such calendar years; and provided further that the first payment of Severance Benefits shall include all amounts
of Severance Benefits that would have been paid to Executive prior to the first payment date but for the application of this sentence.

 

6. RESTRICTIVE COVENANTS.

 

a) Acknowledgment.
Executive acknowledges and agrees that: (i) the Company and its Affiliates (collectively, the Company and its Affiliates,
including its Affiliates as a result of the occurrence of the transactions contemplated by the Merger Agreement, are referred to
in this Section 6 as the “Company Affiliated Group”), have acquired and established, at great expense
and effort, valuable and competitively sensitive Confidential Information (as defined below), including trade secrets, and, to
protect the business interests of the Company Affiliated Group and the competitive advantage derived from the Confidential Information,
it is necessary that such Confidential Information be kept secret and confidential at all times during and after the duration of
Executive’s employment or affiliation with the Company Affiliated Group in accordance with applicable law; (ii) in the
course of Executive’s employment and/or other affiliation with the Company, Executive will be engaged in activities whereby
Executive will have extensive access to and become intimately familiar with, and may develop or contribute to, the Confidential
Information, which information is vital to the success of the Company Affiliated Group, and the disclosure or use of which information
outside the Company Affiliated Group would result in extensive and irreparable harm; (iii) through great effort and at an
incalculable expense, the Company Affiliated Group has developed and maintained, and will continue to develop and maintain, invaluable
business relationships (contractual and prospective) with the Company Affiliated Group’s employees, clients, customers, prospective
customers, independent contractors, vendors, and suppliers, which business relationships are vital to the Company Affiliated Group’s
success; (iv) the restrictive covenants set forth in this Section 6 are reasonable and necessary in order to protect
and maintain such proprietary interests and the other legitimate business interests of the Company Affiliated Group and that such
restrictive covenants in this Section 6 shall survive the termination of Employee’s employment with the Company for
any reason; (v) the Company would not have entered into this Agreement unless such covenants were included herein; and (vi) these
covenants are entered into by Executive in consideration of the opportunity to receive severance and other consideration pursuant
to this Agreement.

 

    7

     

    

 

b) Non-Competition.
Executive shall not engage in any other business activity or occupation during the Term without the prior written consent of the
Board. Executive shall not engage in any activity which is or may present a conflict of interest or materially interfere with Executive’s
duties hereunder. In addition, Executive covenants and agrees that for a period commencing on the Effective Date and ending eighteen
(18) months following the last day of Executive’s employment or affiliation with the Company Affiliated Group (the “Separation
Date”) regardless of the reason for the termination of Employee’s employment or affiliation (such period, the
“Restricted Period”), Executive shall not, without the written consent of the Board, engage, directly
or indirectly, whether as an individual, sole proprietor, or as a principal, agent, officer, director, employer, employee, consultant,
independent contractor, partner or shareholder of any firm, corporation or other entity or group or otherwise, in any Competing
Business. For purposes of this Agreement, the term “Competing Business” means any individual, sole proprietorship,
partnership, firm, corporation or other entity or group which offers or sells or attempts to offer or sell (i) factual film,
television and digital audio-visual products or services (e.g., Discovery Communications, A&E Networks, Smithsonian
Network, BBC), unless Executive’s services to such Competing Business do not relate in any respect to the factual film, television
or digital audio-visual business of such Competing Business, or (ii) any other products or services offered or sold by the
Company Affiliated Group at any point during the twelve (12) month period prior to Employee’s Separation Date. Executive
may passively invest in private companies that do not compete with the Company, and in respect of which Executive provides no time
or attention, and Executive may own, of record or beneficially, as a passive investment, not more than three percent (3%) of the
outstanding securities of any publicly traded stock, in each case so long as such investments do not interfere with the performance
of Executive’s responsibilities as an employee of the Company and are not inconsistent with the Company’s policies.
In addition, Executive may donate his time to, or serve or boards of, charitable or philanthropic organizations provided that such
activities do not interfere with the performance of his duties hereunder and are not inconsistent with the Company’s policies.

 

c) Non-Solicitation.
Executive agrees that during the Restricted Period, he shall not, without the written consent of the Board, directly or indirectly,
on Executive’s own behalf or on behalf of any other person or entity (other than the Company Affiliated Group), solicit the
trade or business of any customer, supplier or vendor with whom the Company Affiliated Group conducts business or otherwise has
a business relationship, in connection with the sale or provision of any factual film, television and digital audio-visual products
or services. Executive agrees further that during the Restricted Period, he shall not, without the written consent of the Board,
on Executive’s own behalf or on behalf of any other person or entity (other than the Company Affiliated Group), directly
or indirectly: (i) solicit, recruit or hire, or attempt to solicit, recruit or hire, any employee of the Company Affiliated
Group; (ii) induce or attempt to induce any employee or independent contractor to leave the employ of or cease doing business with
the Company or any other member of the Company Affiliated Group.

 

    8

     

    

 

f)
Non-Interference. Executive agrees that during the Restricted Period, Executive shall not, without the written consent of
the Board, on Executive’s own behalf or on behalf of any other person or entity (other than the Company Affiliated Group),
directly or indirectly, induce any customer or client, vendor, supplier or other contracting party or business partner of the Company
Affiliated Group to discontinue, terminate, cancel, disrupt or not renew a business relationship or transaction with any member
of the Company Affiliated Group, or otherwise interfere with a business relationship or transaction between any such parties and
one or more members of the Company Affiliated Group.

 

g) No Unauthorized
Possession, Disclosure or Use of Confidential Information and Trade Secrets.

 

i. For purposes hereof,
“Confidential Information” shall mean and include all information regarding the Company Affiliated Group,
its activities, business or customers that is not generally disclosed by practice or authority to persons not employed by the Company.
Confidential Information shall include, without limitation, all technical and non-technical data, compilations, programs and methods,
techniques, drawings, processes, financial data, actual and prospective customer lists, actual and prospective contractor lists,
actual and prospective consultant lists, documents containing the names, addresses and/or other contact information of current
or former customers of the Company Affiliated Group, documents reflecting past or present buying patterns or habits, sales reports,
service reports, price lists and discount lists, methods and/or procedures regarding pricing, product cost and profit strategies
or structures, product formulae, methods and/or procedures related to sales or services, methods and/or procedures of operation,
and/or management planning information, or other like information, which is communicated to, supplied to or observed by Executive,
either directly or indirectly, at any time during Executive’s affiliation with the Company Affiliated Group, whether or not
received from the Company or from any actual or potential customer or client of the Company Affiliated Group, or from any person
with a business relationship, whether contractual or otherwise, with the Company Affiliated Group. The term “Confidential
Information” shall not include information that has become generally available to the public by the act of one who has the
right to disclose such information without violating any right or privilege of the Company or any member of the Company Affiliated
Group. This definition shall not operate to limit any definition of “confidential information” or any equivalent term
under any potentially applicable federal or state law, or the scope of any protections afforded by any law governing trade secrets.
To the extent that any Confidential Information rises to the level of a trade secret under such applicable law, the Confidential
Information shall be treated as a Trade Secret under this Agreement. “Trade Secrets” shall mean information
not generally known about the Company’s business or the business of any member of the Company Affiliated Group which is the
subject of efforts that are reasonable under the circumstances to maintain its secrecy or confidentiality and from which the Company
or any member of the Company Affiliated Group derives economic value from the fact that the information is not generally known
to other persons who can obtain economic value from its disclosure or use, and shall include any and all Confidential Information
which may be protected as a trade secret under any applicable law, even if not specifically designated as such.

 

    9

     

    

 

ii. Executive recognizes
the interest of the Company Affiliated Group in maintaining the confidential nature of its Confidential Information and Trade Secrets.
Accordingly, Executive covenants and agrees that Executive will not, at any time, other than in the performance of Executive’s
duties for the Company, both during and after Executive’s employment with the Company, communicate or disclose to any person
or entity, or use for Executive’s benefit, or for the benefit of any other person or entity, either directly or indirectly,
any of the Company’s or any member of the Company Affiliated Group’s Confidential Information and/or Trade Secrets.
Nothing in this Agreement or this Section is intended to impair Executive’s right to engage in concerted protected activity
under Section 7 of the National Labor Relations Act related to Executive’s terms, conditions, wages, or benefits of employment.
However, except as otherwise provided herein, in no event shall Executive make any use or disclosure of Trade Secrets of the Company
or any member of the Company Affiliated Group not expressly authorized in advance in writing by the Board.

 

iii. Nothing in this
Agreement is intended to or shall preclude Executive from: (i) providing truthful testimony on any non-privileged subject
matter in response to a valid subpoena, court order, regulatory request or other judicial, administrative or legal process or otherwise
as required by law, in which event Executive shall notify the Company of the anticipated testimony in writing, unless prohibited
to do so by law or such process, as promptly as practicable after receiving any such request and at least ten (10) business
days prior to providing such testimony (or, if such notice is not possible under the circumstances, with as much prior notice as
is possible) so that the Company may seek a protective order or other appropriate remedy; or (ii) reporting, without any prior
authorization from, or notification to, the Company, possible violations of federal law or regulation to any governmental agency
or entity, including but not limited to the Securities and Exchange Commission, the Department of Justice, the Congress and any
agency Inspector General, or making other disclosures that are protected under the whistleblower provisions of federal or state
law or regulation. If such a protective order or other remedy described in clause (i) of the foregoing sentence is not obtained,
and the Company does not waive compliance with this Agreement, Executive shall furnish only that portion of such subject matter
that is legally required and shall at the Company’s expense exercise all reasonable efforts to obtain reliable assurance
that confidential treatment will be accorded to the subject matter to be disclosed.

 

h) Notice of Immunity
under the Defend Trade Secrets Act. Executive acknowledges and agrees that the Company has provided Executive with written
notice below that the Defend Trade Secrets Act, 18 U.S.C. § 1833(b), provides an immunity for the disclosure of a trade secret
to report a suspected violation of law and/or in an anti-retaliation lawsuit, as follows: An individual shall not be held criminally
or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that is made (1) in confidence
to a Federal, State, or Local government official, either directly or indirectly, or to an attorney; and (2)(A) solely for the
purpose of reporting or investigating a suspected violation of law; or (B) is made in a complaint or other document filed in a
lawsuit or other proceeding, if such filing is made under seal. An individual who files a lawsuit for retaliation by an employer
for reporting a suspected violation of law may disclose the trade secret to the attorney of the individual and use the trade secret
information in the court proceeding, if the individual files any document containing the trade secret under seal; and does not
disclose the trade secret, except pursuant to court order.

 

    10

     

    

 

i) Reasonableness;
Extraordinary Remedies; Tolling. Executive has carefully read and considered the provisions of Section 6, and, having
done so, agrees that the restrictions set forth therein (including but not limited to the scope of defined terms, the time period
of restrictions and the geographical areas of restriction set forth therein) are fair and reasonable and are reasonably required
for the protection of the legitimate business interests of the Company and the Company Affiliated Group. Executive represents that
Executive’s experience, capabilities, and personal assets, as well as the compensation Executive will receive during Executive’s
employment or affiliation with the Company Affiliated Group, are such that Executive’s compliance with Section 6 will
not prevent Executive from either earning a livelihood in the many business activities that are not restricted by this Agreement
or from otherwise adequately and appropriately supporting Executive’s family. Executive further agrees that Executive shall
not assert, or permit to be asserted on Executive’s behalf, in any forum, any position contrary to the foregoing. The parties
acknowledge and agree that the individual covenants in this Agreement are separate and distinct commitments of Executive, independent
of each other covenant hereunder. Accordingly, if, at the time of enforcement of such covenants, a court of competent jurisdiction
or arbitrator holds that the restrictions stated herein are unreasonable under the circumstances then existing, the parties hereto
agree that the maximum period or scope legally permissible under such circumstances will be substituted for the period or scope
stated herein. Executive agrees that a breach of any covenant in this Section 6 would result in irreparable and continuing
damage to the Company Affiliated Group and shall constitute a separate and independent material breach of this Agreement for which
the applicable member(s) of the Company Affiliated Group may pursue its or their remedies hereunder or as otherwise allowed by
law. In the event of a breach or threatened breach of any covenant in Section 6, it is understood and agreed that the Company
and/or other applicable member(s) of the Company Affiliated Group shall be entitled to pursue temporary, preliminary and/or final
injunctive relief without the necessity of posting any bond or similar security in connection with such action, as well as other
applicable remedies at law or in equity available to the Company and/or applicable member(s) of the Company Affiliated Group against
Executive or others. Such remedy shall be in addition to and not in lieu or limitation of any injunctive relief, other damages,
or other rights or remedies to which the Company and/or other applicable member(s) of the Company Affiliated Group are or may be
entitled at law or in equity under this Agreement or otherwise. Executive agrees that the applicable period of each such restrictive
covenant in Section 6 shall be tolled during any period of time in which Employee is in breach or violation of the terms thereof,
in order that the Company Affiliated Group shall have all of the agreed-upon temporal protection thereunder. Executive acknowledges
and agrees that if Executive violates any of the covenants in Section 6, the Company and/or applicable member(s) of the Company
Affiliated Group shall be entitled to an accounting and repayment of all profits, compensation, fees, commissions, remunerations
or benefits which Executive, directly or indirectly, has realized and/or may realize as a result of, growing out of, or in connection
with, any such violation. Such remedy shall be in addition to and not in limitation of any injunctive relief, other damages, or
other rights or remedies to which the Company and/or applicable member(s) of the Company Affiliated Group is or may be entitled
at law or in equity under this Agreement or otherwise. The covenants provided for in this Section 6 shall survive the termination
of this Agreement and of Executive’s employment and shall survive the expiration of this Agreement and of Executive’s
employment; provided that, in the event Executive’s employment terminates following the expiration of the Term (and
not pursuant to Section 5), the application of the non-competition provisions set forth in Section 6(b) shall be conditioned upon,
and shall apply for so long as (but not to exceed the Restricted Period), the Company continues to pay Executive his Base Salary
as in effect on the date of his termination of employment.

 

j) Return of Company
Property. Executive acknowledges that Trade Secrets and Confidential Information are essential to the Company’s business.
Executive agrees that either (a) within five (5) business days of the Company’s request or (b) upon the cessation of Executive’s
employment, Executive will immediately return to the Company any and all Company property and documents and other tangible media
containing Company Trade Secrets and Confidential Information (and all copies thereof) in Executive's possession, custody or control.

 

    11

     

    

 

7. COOPERATION. Upon the receipt
of reasonable notice from the Company (including outside counsel), Executive agrees that, while employed by the Company and thereafter
for a period of twenty-four (24) months, Executive will at the Company’s expense: (i) respond and provide information
with regard to matters in which Executive has knowledge as a result of Executive’s employment with the Company, (ii) 
provide reasonable assistance to the Company, its Affiliates and their respective representatives in defense of any claims that
may be made against the Company or its Affiliates, and (iii)  assist the Company and its Affiliates in the prosecution of
any claims that may be made by the Company or its Affiliates, to the extent that such claims may relate to the period of Executive’s
employment with the Company (collectively, the “Claims”). Executive agrees to promptly inform the Company
if Executive becomes aware during his employment of any lawsuits involving Claims that may be filed or threatened against the Company
or its Affiliates. During Executive’s employment with the Company and for the twenty-four (24) month period thereafter, Executive
also agrees to promptly inform the Company (to the extent that Employee is legally permitted to do so) if Executive is asked to
assist in any investigation of the Company or its Affiliates (or their actions) or another party attempts to obtain information
or documents from Executive (other than in connection with any litigation or other proceeding in which Executive is a party-in-opposition) with
respect to matters Executive believes in good faith to relate to any investigation of the Company or its Affiliates, in each case,
regardless of whether a lawsuit or other proceeding has then been filed against the Company or its Affiliates with respect to such
investigation, and shall not do so unless legally required. During the pendency of any litigation or other proceeding involving
Claims, Executive shall not communicate with anyone (other than Executive’s attorneys and tax and/or financial advisors and
except to the extent that Executive determines in good faith is necessary in connection with the performance of Executive’s
duties hereunder) with respect to the facts or subject matter of any pending or potential litigation or regulatory or administrative
proceeding involving the Company or any of its Affiliates without giving prior written notice to the Company or the Company’s
counsel.

 

8. APPLICABILITY OF SECTION 409A OF
THE CODE. Notwithstanding anything herein to the contrary, the parties intend that this Agreement, to the maximum extent possible,
be administered, interpreted and construed in a manner consistent with Section 409A of the Internal Revenue Code of 1986, as amended
(the “Code”), and the Treasury Regulations and Internal Revenue Service guidance thereunder (collectively,
“Section 409A”). Neither party individually or in combination may accelerate, offset or assign any payment
subject to Section 409A, except in compliance with Section 409A.  No amount shall be paid prior to the earliest date on which
it is permitted to be paid under Section 409A and Executive shall have no discretion with respect to the timing of payments except
as permitted under Section 409A. Notwithstanding anything herein to the contrary, to the extent necessary to avoid the imposition
of tax on Executive under Section 409A, any payments that are otherwise payable to Executive within the first six (6) months following
the effective date of termination of employment shall be suspended and paid as soon as practicable following the end of the six-month
period following such effective date if, immediately prior to Executive’s termination of employment, Executive is determined
to be a “specified employee” (within the meaning of Section 409A(a)(2)(B)(i)) of the Company (or any related “service
recipient” within the meaning of Section 409A). Any payments suspended by operation of the foregoing sentence shall be paid
as a lump sum within thirty (30) days following the end of such six-month period. Payments (or portions thereof) that would be
paid latest in time during the six-month period will be suspended first. For purposes of this Agreement, the phrases “termination
of employment,” “termination,” “terminated,” and similar terminology all refer to a “separation
from service” within the meaning of Section 409A. Each payment and each installment of any severance payments provided for
under this Agreement shall be treated as a separate payment for purposes of application of Section 409A. All expense reimbursement
or in-kind benefits subject to Section 409A which are provided under this Agreement or, unless otherwise specified in writing,
under any Company program or policy shall be subject to the following rules: (i) any such expense reimbursement shall be made by
the Company no later than the last day of the taxable year following the taxable year in which such expense was incurred by Executive,
(ii) the right to reimbursement or in-kind benefits shall not be subject to liquidation or exchange for another benefit, and (iii)
the amount of expenses eligible for reimbursement or in-kind benefits provided during any taxable year shall not affect the expenses
eligible for reimbursement or in-kind benefits to be provided in any other taxable year; provided, that the foregoing clause
shall not be violated with regard to expenses reimbursed under any arrangement covered by Section 105(b) of the Code solely because
such expenses are subject to a limit related to the period the arrangement is in effect. In no event whatsoever shall the Company
be liable for any additional tax, interest or penalty that may be imposed on Executive by Section 409A or damages for failing
to comply with Section 409A.

 

    12

     

    

 

9. SECTION 280G. To the extent that
any or all of the payments and benefits provided for in this Agreement and pursuant to any other plans or agreements with Executive
constitute “parachute payments” within the meaning of Section 280G of the Code and, but for this Section 9, would be
subject to the excise tax imposed by Section 4999 of the Code (“Excise Tax”), then: either, (i) such
payments shall be delivered in full or (ii) the aggregate amount of the payments and benefits under this Agreement and such other
arrangements shall be reduced such that the present value (as determined under the Code and applicable regulations) of all payments
constituting “parachute payments”, is equal to 2.99 times Executive’s “base amount” (as defined in
the Code), whichever of the foregoing amounts, taking into account the applicable federal, state and local income taxes and the
Excise Tax, results in the receipt by Executive on an after-tax basis, of the greatest amount of benefits, notwithstanding that
all or some portion of such benefits may be taxable under Section 4999 of the Code. The reduction of the payments due hereunder,
if applicable, shall be made by first reducing the payments to be made latest in time and if multiple portions of the payments
are to be paid at the same time, any non-cash payments will be reduced before cash payments, and any remaining cash payments will
be reduced pro rata. Unless the Company and Executive otherwise agree in writing, any determination required under this Section
9 shall be made in writing in good faith by an accounting firm chosen by the Company and reasonably acceptable to Executive (the
“Accountants”). If a reduction in benefits is required under this Agreement and one or more other arrangements
or plans entered into with or maintained for the benefit of Executive that provides for vesting acceleration of equity awards,
cash severance or retention benefits, and/or continued employee benefits coverage, the reduction will occur in the following order:
the vesting acceleration of stock options or stock appreciation rights, then cash severance, bonuses or retention benefits, then
vesting acceleration of equity awards other than stock options or stock appreciation rights, and then Company-paid employee benefits
coverage. In the event that acceleration of vesting of stock options, stock appreciation rights or other equity awards is to be
reduced, such acceleration of vesting shall be cancelled in the reverse order of the date of grant for Executive’s stock
options, stock appreciation rights or other equity awards, as applicable. For purposes of making the calculations required hereunder,
the Accountants may make reasonable assumptions and approximations concerning applicable taxes and may rely on reasonable, good
faith interpretations concerning the application of Sections 280G and 4999 of the Code. The Company and Executive shall furnish
to the Accountants such information and documents as the Accountants may reasonably request in order to make a determination under
this Section. The Company shall bear all costs the Accountants may incur in connection with any calculations contemplated by this
Section.

 

    13

     

    

 

10. DIVISIBILITY OF AGREEMENT. In
the event that any term, condition or provision of this Agreement is for any reason rendered void, all remaining terms, conditions
and provisions shall remain and continue as valid and enforceable obligations of the parties hereto.

 

11. NOTICES. Any notices or other
communications required or permitted to be sent hereunder shall be in writing and shall be duly given if (a) delivered personally,
(b) sent by certified or registered mail, postage pre-paid and return receipt requested, (c) sent by prepaid overnight courier
service, delivery confirmed, or (d) sent by email with confirmation and acknowledgment of receipt, addressed as follows:

 

a) If to
Executive:

 

Clint Stinchcomb

_________________

_________________

Email: ___________

 

With a copy (which
shall not constitute notice) to:

 

Loeb & Loeb
LLP

10100 Santa Monica
Blvd., Suite 2200

Los Angeles,
CA 90067

Attention: Steve
Hurdle

Email: shurdle@loeb.com

 

b) If to the Company:

 

Curiosity Stream,
Inc.

8484 Georgia Avenue, Suite 700

Silver Spring, MD 20910

Attention: John
Hendricks

Email: john.hendricks@hihllc.com

 

with a copy (which shall not constitute
notice) to:

 

Arnold &
Porter LLP

250 West 55th Street

New York, NY 10019

Attention: Christopher Peterson and Charles Wachsstock

Email: Christopher.peterson@arnoldporter.com

    Charlie.wachsstock@arnoldporter.com

 

Either party may change its address for
the sending of notice to such party by written notice to the other party sent in accordance with the provisions hereof.

 

    14

     

    

 

12. COMPLETE AGREEMENT. This Agreement
contains the entire understanding of the parties with respect to the employment of Executive and supersedes all prior arrangements
or understandings with respect thereto and all oral or written employment agreements or arrangements between the Company (and any
of its subsidiaries) and Executive. This Agreement may not be altered or amended except by a writing, duly executed by the party
against whom such alteration or amendment is sought to be enforced. Executive understands and agrees that the Company may arrange
for an Affiliate of the Company to provide payroll and other services in respect of Executive.

 

13. ASSIGNMENT. This Agreement is
personal and non-assignable by Executive. It shall inure to the benefit of any corporation or other entity with which the Company
shall merge or consolidate or to which the Company shall lease or sell all or substantially all of its assets, and may be assigned
by the Company to any Affiliate of the Company or to any corporation or entity with which such Affiliate shall merge or consolidate
or which shall lease or acquire all or substantially all of the assets of such Affiliate; provided, that, as a condition
to such sale of assets or merger, the purchaser or surviving company, as the case may be, shall have assumed the obligations of
the Company under this Agreement

 

14. COUNTERPARTS. This Agreement
may be executed in counterparts, each of which shall be an original and all of which together shall constitute one and the same
instrument.

 

15. GOVERNING LAW; EXCLUSIVE JURISDICTION.
All questions concerning the construction, validity and interpretation of this Agreement and any disputes relating to or arising
under this Agreement shall be governed by the internal law, and not the law of conflicts, of the State of Maryland. All disputes
relating to or arising under this Agreement shall be litigated exclusively in the federal or state courts in the State of Maryland
and Executive and the Company consent to the exclusive jurisdiction of such courts in any such action or proceeding and hereby
waive any objection to venue lying therein.

 

[signature page follows]

 

    15

     

    

  

IN WITNESS WHEREOF,
each of the parties hereto has executed this Agreement in multiple counterparts as of the day and year first above written.

 

	 	EMPLOYEE:
	 	 
	 	/s/ Clint Stinchcomb
	 	Clint Stinchcomb
	 	 
	 	CURIOSITYSTREAM INC.
	 	 	 
	 	By:	/s/ John S. Hendricks
	 	Name:	John S. Hendricks
	 	Title:	Chairman

 

    16

     

    

  

Attachment A

 

Annual Bonus Goals

 

Except for calendar year 2020, Executive’s
100% annual bonus target shall be divided equally (50/50) between Company’s achievement of (1) the revenue target, and (2)
the net income or (loss) target indicated below during each respective calendar year.

 

	Calendar Year	 	Revenue Target	 	 	Net Income (Loss)
	2020	 	$	36,000,000	 	 	N/A
	2021	 	$	71,000,000	 	 	To be determined by the Committee following consultation with Executive prior to the beginning of 2021
	2022	 	$	136,000,000	 	 	To be determined by the Committee following consultation with Executive prior to the beginning of 2022

 

 

17Exhibit 10.11

 

REGISTRATION
RIGHTS AGREEMENT

 

This
REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of November 20, 2018, by
and among CuriosityStream Inc., a Delaware corporation (together with any successor entity thereto, the “Company”),
and Stifel, Nicolaus & Company, Incorporated, a Missouri corporation (“Stifel”), in its capacity as
the initial purchaser/placement agent and in its capacity as a purchaser of the Company’s Series A Convertible Preferred
Stock, $0.01 par value per share (“Preferred Stock”), for the benefit of Stifel, the purchasers (“Participants”)
of shares of Preferred Stock, in the private offering by the Company of the Preferred Stock, and the direct and indirect transferees
of Stifel and each of the Participants. The shares of Preferred Stock are convertible into shares of the Company’s Class
A common stock, $0.01 par value per share (“Class A Common Stock”), pursuant to the terms set forth in
the Certificate of Designations for the Preferred Stock (the “Certificate of Designations”).

 

This
Agreement is made pursuant to the Purchase/Placement Agreement (the “Purchase/Placement Agreement”), dated
as of November 15, 2018, between the Company and Stifel in connection with the purchase and sale or placement of an aggregate
of 14,500,000 shares of Preferred Stock (plus up to an additional 2,175,000 shares of Preferred Stock that Stifel has the option
to purchase or place to cover additional allotments, if any), including the purchase by Stifel of up to 125,000 shares of Preferred
Stock for its own account. In order to induce Stifel to enter into the Purchase/Placement Agreement, the Company has agreed to
provide the registration rights provided for in this Agreement to Stifel, the Participants and their respective direct and indirect
transferees. The execution of this Agreement is a condition to the closing of the transactions contemplated by the Purchase/Placement
Agreement.

 

The
parties hereto hereby agree as follows:

 

1. Definitions

 

As
used in this Agreement, the following terms shall have the following meanings:

 

Accredited
Investor Shares: The Preferred Stock initially sold by the Company to “accredited investors” (within the
meaning of Rule 501(a) promulgated under the Securities Act) as Participants.

 

Affiliate:
As to any specified Person, as defined in Rule 12b-2 under the Exchange Act.

 

Agreement:
As defined in the preamble.

 

Board
of Directors: As defined in Section 2(a)(iv) hereof.

 

Business
Day: With respect to any act to be performed hereunder, each Monday, Tuesday, Wednesday, Thursday and Friday that is not a
day on which banking institutions in New York, New York or other applicable places where such act is to occur are authorized or
obligated by applicable law, regulation or executive order to close.

 

Bylaws:
The Amended and Restated Bylaws of the Company, adopted as of the date hereof, as amended from time to time.

 

Certificate
of Designations: As defined in the preamble.

 

Class A
Common Stock: As defined in the preamble.

 

Closing
Date: November 20, 2018 or such other time or such other date as Stifel and the Company may agree.

 

Commission:
The U.S. Securities and Exchange Commission.

 

Company:
As defined in the preamble.

 

Company
Charter: The Company’s amended and restated certificate of incorporation, as amended from time to time.

 

Controlling
Person: As defined in Section 6(a) hereof.

 

    1

     

    

  

Effectiveness
Deadline: As defined in Section 2(a) hereof.

 

End
of Suspension Notice: As defined in Section 5(b) hereof.

 

Exchange
Act: The Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated by the Commission pursuant
thereto.

 

Extension
Proposal: As defined in Section 2(a)(ii)(B) hereof.

 

Filing
Deadline: As defined in Section 2(a)(i) hereof.

 

FINRA:
The Financial Industry Regulatory Authority, Inc.

 

Holder:
Each record owner of any Preferred Stock or Registrable Shares from time to time, including Stifel and its Affiliates to the
extent Stifel or any such Affiliate holds any Preferred Stock or Registrable Shares.

 

Indemnified
Party: As defined in Section 6(c) hereof.

 

Indemnifying
Party: As defined in Section 6(c) hereof.

 

IPO:
As defined in Section 2(b)(ii) hereof.

 

IPO
Registration Statement: As defined in Section 2(b) hereof.

 

Issuer
Free Writing Prospectus: As defined in Section 2(d) hereof.

 

JOBS
Act: The Jumpstart Our Business Startups Act of 2012, as amended, and the rules and regulations promulgated by the Commission
thereunder.

 

Liabilities:
As defined in Section 6(a) hereof.

 

Marketed
Shelf Takedown: As defined in Section 2(a)(ii) hereof.

 

National
Securities Exchange: The New York Stock Exchange, The NYSE American Stock Exchange, Nasdaq Global Market or any similar national
securities exchange.

 

Participants:
As defined in the preamble.

 

Person:
An individual, partnership, corporation, limited liability company, trust, unincorporated organization, government or agency
or political subdivision thereof, or any other legal entity.

 

Preferred
Stock: As defined in the preamble.

 

Proceeding:
An action (including a class action), claim, suit or proceeding (including without limitation, an investigation or partial
proceeding, such as a deposition), whether commenced or, to the knowledge of the Person subject thereto, threatened.

 

Prospectus:
The prospectus included in any Registration Statement, including any preliminary prospectus at the applicable “time
of sale” within the meaning of Rule 159 under the Securities Act and all other amendments and supplements to any such
prospectus, including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference,
if any, in such prospectus.

 

Purchase/Placement
Agreement: As defined in the preamble.

 

Purchaser
Indemnitee: As defined in Section 6(a) hereof.

 

    2

     

    

 

Registrable
Shares: The shares of Class A Common Stock issuable upon conversion of the Rule 144A Shares, the Accredited Investor
Shares, the Stifel Purchased Shares and the Regulation S Shares, upon original issuance thereof pursuant to the terms and
conditions of the Purchase/Placement Agreement and at all times subsequent thereto, including upon the transfer thereof by the
original holder or any subsequent holder (excluding any transfer under clauses (i), (ii) or (iii) below), and any
shares or other securities issued in respect of such Registrable Shares by reason of or in connection with any stock dividend,
stock distribution, stock split, purchase in any rights offering or in connection with any exchange, conversion or replacement
of such Registrable Shares or any combination of shares, recapitalization, merger or consolidation, or any other equity securities
of the Company issued pursuant to any other pro rata distribution with respect to the Class A Common Stock, until, in the
case of any such securities, the earliest to occur of (i) the date on which the resale of such security has been registered
pursuant to the Securities Act and it has been disposed of in accordance with the Registration Statement relating to it, (ii) the
date on which such securities either have been transferred pursuant to Rule 144 (or any similar provision then in effect)
or are freely saleable, without condition pursuant to Rule 144, including any current public information requirements, and
are listed for trading on a National Securities Exchange, or (iii) the date on which such securities are sold to the Company.

 

Registration
Expenses: Any and all fees and expenses incident to the performance of or compliance with this Agreement, including, without
limitation: (i) all Commission, securities exchange, FINRA or other registration, listing, inclusion and filing fees; (ii) all
fees and expenses incurred in connection with compliance with international, federal or state securities or blue sky laws (including,
without limitation, any registration, listing and filing fees and reasonable fees and disbursements of counsel in connection with
blue sky qualification of any of the Registrable Shares and the preparation of a blue sky memorandum and compliance with the rules
of FINRA); (iii) all expenses in preparing or assisting in preparing, word processing, duplicating, printing, delivering
and distributing any Registration Statement, any Prospectus, any amendments or supplements thereto, any underwriting agreements,
securities sales agreements, certificates and any other documents relating to the performance under and compliance with this Agreement;
(iv) all fees and expenses incurred in connection with the listing or inclusion of any of the Registrable Shares on any securities
exchange pursuant to Section 4(m) of this Agreement; (v) the fees and disbursements of counsel for the Company and of
the independent registered public accounting firm of the Company (including, without limitation, the expenses of any special audit
and “cold comfort” letters required by or incident to the performance of this Agreement); (vi) reasonable and
documented fees and disbursements of one counsel to the Holders reasonably acceptable to the Company and Stifel, with respect
to a review of the Registration Statement and other offering arrangements for the Holders (such counsel, “Review Counsel”)
in an amount not to exceed $100,000 with respect to any Registration Statement or firm commitment underwriting; and (vii) any
fees and disbursements customarily paid in issues and sales of securities (including the fees and expenses of any experts retained
by the Company in connection with any Registration Statement); provided, however, that Registration Expenses shall
exclude brokers’ or underwriters’ discounts and commissions, if any, all transfer taxes and transfer fees relating
to the sale or disposition of Registrable Shares by a Holder, and the fees and expenses of counsel to any Holder other than the
fees and expenses of Review Counsel.

 

Registration
Statement: Any registration statement of the Company filed or confidentially submitted with the Commission under the Securities
Act that covers the resale of Registrable Shares pursuant to the provisions of this Agreement, including the Prospectus, amendments
and supplements to such registration statement or Prospectus, including pre- and post-effective amendments, all exhibits thereto
and all material incorporated by reference or deemed to be incorporated by reference, if any, in such registration statement.

 

Regulation S:
Regulation S (Rules 901-905) promulgated by the Commission under the Securities Act, as such rules may be amended
from time to time, or any similar rule or regulation hereafter adopted by the Commission as a replacement thereto having substantially
the same effect as such regulation.

 

Regulation S
Shares: The Preferred Stock initially resold by Stifel pursuant to the Purchase/Placement Agreement to “non-U.S. persons”
(in accordance with Regulation S) in an “offshore transaction” (in accordance with Regulation S).

 

Review
Counsel: As defined in paragraph (vi) of the definition for Registration Expenses.

 

    3

     

    

 

Rule 144A
Shares: The Preferred Stock initially resold by Stifel pursuant to the Purchase/Placement Agreement to “qualified institutional
buyers” (as such term is defined in Rule 144A).

 

Securities
Act: The Securities Act of 1933, as amended, and the rules and regulations promulgated by the Commission thereunder. Any reference
to a “Rule” number herein, unless otherwise specified, shall be a reference to such Rule number promulgated by the
Commission pursuant to the Securities Act, as such rule may be amended from time to time, or any similar rule or regulation hereafter
adopted by the Commission as a replacement thereto having substantially the same effect as such rule.

 

Shelf
Registration Statement: As defined in Section 2(a)(i) hereof.

 

Shelf
Supplement: As defined in Section 2(a)(ii) hereof.

 

Shelf
Takedown: As defined in Section 2(a)(ii) hereof.

 

Shelf
Takedown Notice: As defined in Section 2(a)(ii) hereof.

 

Special
Meeting: As defined in Section 2(a)(ii) hereof.

 

Stifel:
As defined in the preamble.

 

Stifel
Purchased Shares: The Preferred Stock initially purchased by Stifel pursuant to the Purchase/Placement Agreement.

 

Suspension
Event: As defined in Section 5(b) hereof.

 

Suspension
Notice: As defined in Section 5(b) hereof.

 

Underwritten
Offering: A sale of securities of the Company to an underwriter or underwriters for re-offering to the public.

 

Voting
Shares: The following capital stock of the Company, collectively: (i) the outstanding shares of Class A Common Stock issued
upon conversion of the Preferred Stock, and (ii) the outstanding shares of the Preferred Stock, voting on an “as converted”
basis as if such shares of Preferred Stock were converted into shares of Class A Common Stock at the then current Conversion Rate
(as defined in the Certificate of Designation).

 

		2.	Registration
                                         Rights

 

(a)
Mandatory Shelf Registration and Listing.

 

(i)
Registration and Listing. As set forth in Section 4 hereof, the Company agrees to file with the Commission on or before
the first to occur of (i) the 60th day following the closing date of its IPO pursuant to the IPO Registration
Statement and (ii) November 20, 2019 (the “Filing Deadline”) a shelf Registration Statement on Form S-1,
or such other form under the Securities Act then available to the Company, providing for the resale of any Registrable Shares
pursuant to Rule 415, from time to time, by the Holders (a “Shelf Registration Statement”). Subject to
Section 2(b)(iii) hereof, the Company agrees to use its commercially reasonable efforts to cause such Shelf Registration
Statement to be declared effective by the Commission on or before the date that is six months following the Filing Deadline (the
“Effectiveness Deadline”). Subject to Section 2(c) hereof, the Company agrees to cause the Registrable
Shares to be listed on a National Securities Exchange by the Effectiveness Deadline. Any Shelf Registration Statement shall provide
for the resale from time to time, and pursuant to any method or combination of methods legally available (including, without limitation,
an Underwritten Offering, a direct sale to purchasers or a sale through brokers or agents) to the Holders of any and all Registrable
Shares.

 

    4

     

    

 

(ii) At
any time that the Shelf Registration Statement is effective, if one or more Holders deliver a notice to the Company (a “Shelf
Takedown Notice”) stating that the Holder(s) intends to effect an offering of all or part of its Registrable Shares
included in such Shelf Registration Statement (a “Shelf Takedown”) and the Company is eligible to use the Shelf
Registration Statement for such Shelf Takedown, then the Company shall take all actions reasonably required, including amending
or supplementing (a “Shelf Supplement”) the Shelf Registration Statement, to enable such Registrable Securities
to be offered and sold as contemplated by such Shelf Takedown Notice; provided that in the case of each such Shelf Takedown, such
Holder or Holders will be entitled to make such demand only if the proceeds from the sale of Registrable Shares in the Shelf Takedown
(before the deduction of underwriting discounts) is reasonably expected to exceed, in the aggregate, $25 million. Each Shelf
Takedown Notice shall specify the number of Registrable Securities to be offered and sold under the Shelf Takedown. Except in
connection with an underwritten overnight “block trade,” upon receipt of a Shelf Takedown Notice, the Company shall
promptly (but in no event later than ten days following receipt thereof) deliver notice of such Shelf Takedown Notice to all other
holders of Registrable Securities who shall then have five days from the date such notice is given to notify the Company in writing
of their desire to be included in such Shelf Takedown. The Company shall prepare and file with the Commission a Shelf Supplement
as soon as practicable after the date on which it received the Shelf Takedown Notice and, if such Shelf Supplement is an amendment
to the Shelf Registration Statement, shall use its commercially reasonable efforts to cause such Shelf Supplement to be declared
effective by the Commission as soon as practicable thereafter. At the request of such Holders, the plan of distribution for a
Shelf Takedown may include a customary “road show” (including an “electronic road show”) or other substantial
marketing effort by the Company and the underwriters over a period not to exceed 48 hours (a “Marketed Shelf Takedown”).
Subject to the other limitations contained in this Agreement, the Company will not be obligated hereunder to effect a Shelf Takedown
within 90 days after the closing of a Shelf Takedown. Subject to the terms and conditions of this Agreement, the Holders
shall be entitled to have (i) three Marketed Shelf Takedowns effected pursuant to a request by a Holder pursuant to this
paragraph (b), but no more than one Marketed Shelf Takedown per calendar year, and (ii) no more than three Shelf Takedowns
per calendar year (for the avoidance of doubt, one of which per calendar year may be a Marketed Shelf Takedown). In the case of
a Shelf Takedown that is not a Marketed Shelf Takedown, the Company and its management will not be required to participate in
a roadshow or other marketing effort.

 

(iii) The
Company may postpone for up to 30 days the filing or effectiveness of the Shelf Registration Statement or the filing of a
Shelf Supplement for a Shelf Takedown, if the Board of Directors determines in its reasonable good faith judgment that such Shelf
Registration Statement or Shelf Takedown would (i) materially interfere with a significant acquisition, corporate organization,
financing, securities offering or other similar transaction involving the Company; (ii) require premature disclosure of material
information that the Company has a bona fide business purpose for preserving as confidential; or (iii) render the Company
unable to comply with requirements under the Securities Act or Exchange Act; provided, that in such event the Holders of
a majority of the Registrable Shares initiating such Shelf Takedown shall be entitled to withdraw such request and, if such request
for a Shelf Takedown is withdrawn, such Shelf Takedown shall not count as one of the permitted Shelf Takedowns hereunder. The
Company may postpone for up to 60 days the filing of a Shelf Supplement for a Shelf Takedown, if the Board determines in
its reasonable good faith judgment that such Shelf Takedown would materially prejudice the interests of the other Holders. The
Company may delay the Shelf Registration Statement only once pursuant to this Section 2(a)(iii) or a Shelf Takedown only
twice in any period of 12 consecutive months.

 

(iv)
Special Meeting of Holders. In addition to any permitted postponement under Section 2(a)(iii), in the event that the
Board of Directors of the Company (the “Board”) determines that it is not in the best interest of the Company
to file a Shelf Registration Statement with the Commission on or prior to the Filing Deadline, the Board of Directors shall
call a special meeting of the Holders (the “Special Meeting”) to be held at least three (3) months prior
to the Filing Deadline for the purpose of considering and voting upon an extension of the Filing Deadline by a period not to exceed
one (1) year.

 

(A)
Notice. Not less than fifteen (15) days nor more than twenty-five (25) days before the Special Meeting, the Secretary
of the Company shall give to each Holder entitled to vote at the Special Meeting, at such Holder’s address as it appears
in the share transfer records of the Company, notice in writing setting forth (i) the time and place of the Special Meeting,
and (ii) the purpose for which the Special Meeting has been called.

 

(B)
Purpose of the Meeting. The sole purpose of the Special Meeting shall be to approve an extension of the Filing Deadline
by a period not to exceed one (1) year (the “Extension Proposal”). At the Special Meeting, the Company’s
management shall present to the Holders the Company’s rationale for the proposed extension of the Filing Deadline.

 

    5

     

    

 

(C)
Voting Eligibility. All Holders of Voting Shares shall be entitled to vote, as a single class, upon the Extension Proposal;
provided that John S. Hendricks, any officer or director of the Company, and any of their respective Affiliates that hold
Voting Shares shall not be entitled to vote upon the Extension Proposal.

 

(D)
Voting Requirement. The Extension Proposal must be approved by the affirmative vote, in person or by proxy, by the Holders
of at least a majority of the outstanding Voting Shares entitled to vote at the Special Meeting.

 

(b)
IPO Registration. If the Company proposes to file a registration statement on Form S-1 or such other form under
the Securities Act providing for the initial public offering of the Class A Common Stock (the “IPO Registration
Statement”), it being understood that a public offering conducted after the Shelf Registration Statement has become
effective and the Registrable Shares have been listed for trading on a National Securities Exchange shall not be deemed to be
an initial public offering, the Company will notify in writing each Holder of the filing before (but no earlier than ten (10) Business
Days before) or within five (5) Business Days after the initial filing and afford each Holder an opportunity to include in
the IPO Registration Statement all or any part of the Registrable Shares then held by such Holder. Each Holder desiring to include
in the IPO Registration Statement all or part of the Registrable Shares held by such Holder shall, within ten (10) business
days after receipt of the above-described notice from the Company, so notify the Company in writing, and in such notice shall
inform the Company of the number of Registrable Shares such Holder wishes to include in the IPO Registration Statement. Any election
by any Holder to include any Registrable Shares in the IPO Registration Statement will not affect the inclusion of such Registrable
Shares in the Shelf Registration Statement until such Registrable Shares have been sold under the IPO Registration Statement.

 

(i)
Right to Terminate IPO Registration. The Company shall have the right to postpone, terminate or withdraw the IPO Registration
Statement initiated by it and referred to in this Section 2(b) prior to the effectiveness of such registration whether or
not any Holder has elected to include Registrable Shares in such registration; provided, however, the Company must
provide each Holder that elected to include any Registrable Shares in such IPO Registration Statement prompt written notice of
such postponement, termination or withdrawal. Furthermore, in the event the IPO Registration Statement is not declared effective
within one hundred twenty (120) days following the initial filing of the IPO Registration Statement, unless a road show for
the Underwritten Offering pursuant to the IPO Registration Statement is actually in progress at such time or such IPO Registration
Statement has been postponed, terminated or withdrawn pursuant to this Section 2(b)(i), the Company shall promptly provide
a new written notice to all Holders giving them another opportunity to elect to include Registrable Shares in the pending IPO
Registration Statement. Each Holder receiving such notice shall have the same election rights afforded such Holder as described
above in this clause (b).

 

(ii)
Selection of Underwriter. If the Company conducts an initial public offering of its equity or equity-linked securities
(an “IPO”), Stifel has the right of first refusal for a period through the closing of the IPO to serve as the co-lead
managing underwriter and the joint book runner (or in any similar capacity) in connection with the IPO. In the event Stifel exercises
its right of first refusal as set forth in the immediately preceding sentence, Stifel shall be named on the cover of any IPO Prospectus
in the upper left relative to the names of the other underwriters participating in the IPO, shall manage all of the “roadshow”
logistics, share allocations and all stabilization transactions in connection with the IPO and shall perform such other customary
tasks of the co-lead managing underwriter and the joint book-runner in an IPO. Stifel’s compensation for serving in such
capacity in connection with the IPO shall be determined by agreement between the Company and Stifel on the basis of compensation
customarily paid to leading investment banks acting as underwriters in similar transactions; provided, however, that Stifel’s
economics in connection with the IPO shall be equal to those economics paid to the most highly compensated member of the underwriting
group, unless otherwise determined by Stifel.

 

(iii)
Shelf Registration Not Impacted by IPO Registration Statement. The Company’s obligation to file the Shelf Registration
Statement pursuant to Section 2(a) hereof shall not be affected by the filing or effectiveness of the IPO Registration Statement.
In addition, the Company’s obligation to file and use its commercially reasonable efforts to cause to become and keep effective
the Shelf Registration Statement pursuant to Section 2(a) hereof shall not be affected by the filing or effectiveness of
an IPO Registration Statement; provided, however, if the Company files or submits to the Commission an IPO Registration
Statement before the effective date of the Shelf Registration Statement and the Company has used and is using commercially reasonable
efforts to pursue the completion of such IPO, the Company shall have the right to defer causing the Commission to declare such
Shelf Registration Statement effective until the first to occur of (A) the 60th day following the closing
date of its IPO pursuant to the IPO Registration Statement and (B) the three month anniversary of the Effectiveness Deadline.

 

    6

     

    

 

Notwithstanding
any provision to the contrary in this Agreement, any amendment to this Section 2(b) shall be valid only if declared advisable
by the Board of Directors and approved by the affirmative vote of at least two-thirds of the outstanding Voting Shares (excluding
for purposes of this vote any Voting Shares owned by John S. Hendricks, any officer or director of the Company, or their respective
Affiliates).

 

(c)
Interim Over-the-Counter Trading. If the Company cannot meet the round-lot stockholder requirements of a National Securities
Exchange by the Effectiveness Deadline, the Company may postpone the listing of the Registrable Shares on a National Securities
Exchange beyond the Effectiveness Deadline if by the Effectiveness Deadline the Company causes the Registrable Shares to be eligible
for trading over the counter on the OTC QB or OTC QX. Immediately after the Company has satisfied the round-lot stockholder requirements
of a National Securities Exchange, it shall apply to have the Registrable Shares listed on a National Securities Exchange and
shall use its commercially reasonable efforts to have the Registrable Shares listed and traded on such National Securities Exchange
as soon as possible thereafter, but in no event more than 60 days thereafter.

 

(d)
Issuer Free Writing Prospectus. The Company represents and agrees that, unless it obtains the consent of the managing underwriter
in connection with any Underwritten Offering of Registrable Shares, and each Holder represents and agrees that, unless it obtains
the prior consent of the Company and any such underwriter, it will not make any offer relating to the Registrable Shares that
would constitute an “issuer free writing prospectus,” as defined in Rule 433 (an “Issuer Free Writing
Prospectus”), or that would otherwise constitute a “free writing prospectus,” as defined in Rule 405,
required to be filed with the Commission. The Company represents that any Issuer Free Writing Prospectus will not include any
information that conflicts with the information contained in any Registration Statement or the related Prospectus (other than
as would not violate the rules and regulations of the Commission), and any such Issuer Free Writing Prospectus, when taken together
with the information in such Registration Statement and the related Prospectus, will not include any untrue statement of a material
fact or omit to state any material fact necessary in order to make the statements therein, in light of the circumstances under
which they were made, not misleading.

 

(e)
Underwriting. The Company shall advise all Holders who elect to include any Registrable Shares in the IPO Registration
Statement of the lead managing underwriter for the Underwritten Offering proposed under the IPO Registration Statement. The right
of any such Holder to include its Registrable Shares in the IPO Registration Statement pursuant to Section 2(b) shall be
conditioned upon such Holder’s participation in such underwriting and the inclusion of such Holder’s Registrable Shares
in the underwriting to the extent provided herein. All Holders proposing to distribute their Registrable Shares through such underwriting
shall enter into an underwriting agreement in customary form with the managing underwriter(s) selected for such underwriting and
complete and execute any questionnaires, irrevocable powers of attorney, indemnities, custody agreements, securities escrow agreements
and other documents, including opinions of counsel, reasonably required under the terms of such underwriting, and furnish to the
Company such information as the Company may reasonably request in writing for inclusion in the Registration Statement; provided,
however, that no Holder shall be required to make any representations or warranties to or agreements with the Company or
the underwriters other than representations, warranties or agreements regarding such Holder and such Holder’s intended method
of distribution and any other representation required by law or reasonably requested by the underwriters.

 

By
electing to include Registrable Shares in the IPO Registration Statement, the Holder of such Registrable Shares shall be deemed
to have agreed not to effect any public sale or distribution of securities of the Company of the same or similar class or classes
of the securities included in the IPO Registration Statement or any securities convertible into or exchangeable or exercisable
for such securities, including a sale pursuant to Rule 144 or Rule 144A, during such periods as reasonably requested
(but in no event for a period longer than thirty (30) days prior to or one hundred eighty (180) days following the effective
date of the IPO Registration Statement) by the representatives of the underwriters, in an Underwritten Offering, or by the Company
in any other registration.

 

Any
Holder of Registrable Shares that elects not to include Registrable Shares in the IPO Registration Statement hereby agrees not
to effect any public sale or distribution of securities of the Company of the same or similar class or classes of the securities
included in the IPO Registration Statement or any securities convertible into or exchangeable or exercisable for such securities,
including a sale pursuant to Rule 144 or Rule 144A, during such periods as reasonably requested (but in no event for
a period longer than thirty (30) days prior to or sixty (60) days following the effective date of the IPO Registration
Statement) by the representatives of the underwriters, in an Underwritten Offering, or by the Company in any other registration.

 

    7

     

    

 

If
any Holder disapproves of the terms of any such underwriting, such Holder may elect to withdraw therefrom by written notice to
the Company and the managing underwriter(s), delivered no later than two (2) Business Days after the IPO price range is communicated
by the Company to such Holder. Any Registrable Shares excluded or withdrawn from such underwriting shall be excluded and withdrawn
from the registration.

 

(f) Notwithstanding
any other provision of this Agreement, if the managing underwriter(s) determine(s) in good faith that marketing factors require
a limitation on the number of shares to be included, then the managing underwriter(s) may exclude shares (including Registrable
Shares) from the IPO Registration Statement and Underwritten Offering, and any shares included in such IPO Registration Statement
and Underwritten Offering shall be allocated first, to the Company, second, to each of the Holders requesting inclusion
of their Registrable Shares in such IPO Registration Statement (on a pro rata basis based on the total number of Registrable
Shares then held by each such Holder who is requesting inclusion) and third, to holders of shares other than the Holders
(on a pro rata basis based on the total number of shares then held by each such holder who is requesting inclusion); provided,
however, that the number of Registrable Shares to be included in the IPO Registration Statement shall not be reduced unless
all other securities of the Company held by (i) officers, directors, other employees of the Company and consultants and (ii) any
other holders of the Company’s capital stock with registration rights that are inferior (with respect to such reduction)
to the registration rights of each of the Holders set forth herein are first entirely excluded from the underwriting and registration.

 

(g)
Expenses. The Company shall pay all Registration Expenses in connection with the registration of the Registrable Shares
pursuant to this Agreement. Each Holder participating in a registration pursuant to this Section 2 shall bear its proportionate
share (based on the total number of Registrable Shares sold in such registration) of all discounts and commissions payable to
underwriters or brokers and all transfer taxes and transfer fees in connection with a registration of Registrable Shares pursuant
to this Agreement.

 

(h)
JOBS ACT Submissions. For purposes of this Agreement, if the Company elects to confidentially submit a draft of the Shelf
Registration Statement with the Commission pursuant to the JOBS Act, the date on which the Company makes such confidential submission
will be deemed the initial filing date of such Shelf Registration Statement.

 

		3.	Rules 144
                                         and 144A Reporting

 

With
a view to making available the benefits of certain rules and regulations of the Commission that may at any time permit the sale
of the Registrable Shares to the public without registration, the Company agrees to:

 

(a) make
and keep “current public information” available, as those terms are understood and defined in Rule 144, at all
times after the effective date of the first registration statement under the Securities Act filed by the Company for an offering
of its securities to the general public;

 

(b) to
file with the Commission in a timely manner all reports and other documents required to be filed by the Company under the Securities
Act and the Exchange Act (at any time after it has become subject to such reporting requirements);

 

(c) so
long as a Holder owns any Preferred Stock or Registrable Shares, if the Company is not required to file reports and other documents
under the Securities Act or the Exchange Act, make available other information as required by, and so long as necessary to permit
sales of Preferred Stock or Registrable Shares pursuant to, Rule 144 or Rule 144A, and in any event make available (either
by mailing a copy thereof, by posting on the Company’s website, by press release or by filing with the Commission) to each
Holder a copy of:

 

(i) the
Company’s annual consolidated financial statements (including at least balance sheets, statements of profit and loss, statements
of stockholders’ equity and statements of cash flows) prepared in accordance with U.S. generally accepted accounting principles
in the United States, accompanied by an audit report of the Company’s independent accountants, no later than ninety (90) days
after the end of each fiscal year of the Company; and

 

    8

     

    

 

(ii) the
Company’s unaudited quarterly consolidated financial statements (including at least balance sheets, statements of profit
and loss, statements of stockholders’ equity and statements of cash flows) prepared in a manner consistent with the preparation
of the Company’s annual financial statements, no later than forty-five (45) days after the end of each of the first
three fiscal quarters of the Company;

 

(d) so
long as the Company is not required to file reports and other documents under the Securities Act and the Exchange Act and the
Registrable Shares are not listed and trading on a National Securities Exchange, hold, a reasonable time after the availability
of such financial statements and upon reasonable notice to the Holders and Stifel (either by mail, by posting on the Company’s
website or by press release), a quarterly investor conference call to discuss such financial statements, which call will also
include an opportunity for the Holders to ask questions of management with regard to such financial statements, and will also
cooperate with, and make management reasonably available to, Stifel personnel in connection with making Company information available
to investors; and

 

(e) so
long as a Holder owns any Preferred Stock or Registrable Shares, furnish to the Holder promptly upon request (i) a written
statement by the Company as to its compliance with the reporting requirements of Rule 144 (at any time after ninety (90) days
after the effective date of the first registration statement filed by the Company for an offering of its securities to the general
public), (ii) a copy of the most recent annual or quarterly report of the Company (unless otherwise publicly available) and
(iii) take such further actions, as a Holder may reasonably request in availing itself of any rule or regulation of the Commission
allowing a Holder to sell any such Registrable Shares without registration.

 

		4.	Registration
                                         Procedures

 

In
connection with the obligations of the Company with respect to any registration pursuant to this Agreement, the Company shall
use its commercially reasonable efforts to effect or cause to be effected the registration of the Registrable Shares under the
Securities Act to permit the sale of such Registrable Shares by the Holder or Holders in accordance with the Holder’s or
Holders’ intended method or methods of distribution, and the Company shall:

 

(a) (i)
notify Stifel and Review Counsel, in writing, at least ten (10) Business Days prior to filing a Registration Statement, of
its intention to file a Registration Statement with the Commission and, as promptly as practicable but in no event later
than five (5) Business Days prior to filing, provide a copy of the Registration Statement to Stifel and Review Counsel for
review and comment (provided that the Company shall not have any obligation to modify any information if the Company expects that
so doing would cause (A) the Registration Statement to contain an untrue statement of a material fact or omit to state any
material fact required to be stated therein or necessary to make the statements therein not misleading or (B) the Prospectus
to contain an untrue statement of a material fact or to omit to state a material fact necessary in order to make the statements
made, in light of the circumstances under which they were made, not misleading); (ii) prepare and file with the Commission,
as specified in this Agreement, a Registration Statement(s), which Registration Statement(s) shall (A) comply as to form
in all material respects with the requirements of the Securities Act and the applicable form and include all financial statements
required by the Commission to be filed therewith and (B) be reasonably acceptable to Stifel, its counsel and Review Counsel;
(iii) at least three (3) Business Days prior to filing, provide a copy of any amendment or supplement to Stifel and
Review Counsel for review and comment; (iv) promptly following receipt from the Commission, provide to Stifel and Review
Counsel copies of any comments made by the staff of the Commission relating to such Registration Statement; (v) at least
three (3) Business Days prior to submission by the Company to the Commission of responses to any comments made by the staff
of the Commission relating to such Registration Statement, provide to Stifel and Review Counsel copies of the Company’s
responses for review and comment; and (vi) use its commercially reasonable efforts to cause such Registration Statement to
become effective as soon as practicable after filing and to remain effective, subject to Section 5 hereof, until the earlier
of (A) such time as all Registrable Shares covered thereby have been sold in accordance with the method or methods of distribution
of such Registrable Shares contemplated by the Registration Statement, (B) there are no Registrable Shares outstanding or
(C) the first anniversary of the effective date of such Registration Statement (subject to extension as provided in Section 5(c)
hereof and the condition that the Registrable Shares have been transferred to an unrestricted CUSIP and are listed or included
on a National Securities Exchange pursuant to Section 4(m) of this Agreement), and can be sold under Rule 144 without
limitation as to manner of sale, volume or current public information; provided, however, that the Company shall
not be required to cause the IPO Registration Statement to remain effective for any period longer than required by law; provided,
further, that if the Company has an effective Shelf Registration Statement on Form S-1 (or other form then available
to the Company) under the Securities Act and becomes eligible to use Form S-3 or such other short-form registration statement
form under the Securities Act, the Company may, upon thirty (30) Business Days prior written notice to all Holders, register
any Registrable Shares registered but not yet distributed under the effective Shelf Registration Statement on such a short-form
Shelf Registration Statement and, once the short-form Shelf Registration Statement is declared effective, de-register such shares
under the previous Registration Statement or transfer the filing fees from the previous Registration Statement (such transfer
pursuant to Rule 429, if applicable) unless any Holder registered under the initial Shelf Registration Statement notifies
the Company within fifteen (15) Business Days of receipt of the Company notice that such a registration under a new Registration
Statement and de-registration of the initial Shelf Registration Statement would interfere with its distribution of Registrable
Shares already in progress, in which case, the Company shall delay the effectiveness of the short-form Registration Statement
and termination of the then-effective initial Registration Statement or any short-form Registration Statement for a period of
not less than thirty (30) days from the date that the Company receives the notice from such Holders requesting a delay;

 

    9

     

    

 

(b) subject
to Section 4(h) hereof, (i) prepare and file with the Commission such amendments and post-effective amendments to each
such Registration Statement as may be necessary to keep such Registration Statement effective for the period described in Section 4(a)
hereof; (ii) cause each Prospectus contained therein to be supplemented by any required Prospectus supplement, and as so
supplemented to be filed pursuant to Rule 424 or any similar rule that may be adopted under the Securities Act; and (iii) comply
with the provisions of the Securities Act with respect to the disposition of all securities covered by each Registration Statement
during the applicable period in accordance with the intended method or methods of distribution by the selling Holders thereof;

 

(c) furnish
to the Holders, without charge, as many copies of each Prospectus, including each preliminary Prospectus, and any amendment or
supplement thereto and such other documents as such Holder may reasonably request, in order to facilitate the public sale or other
disposition of the Registrable Shares, and hereby does consent to the use of such Prospectus, including each preliminary Prospectus,
by the Holders, if any, in connection with the offering and sale of the Registrable Shares covered by any such Prospectus, subject
to Section 5 hereof;

 

(d) use
its commercially reasonable efforts to register or qualify, or obtain exemption from registration or qualification for, all Registrable
Shares by the time the applicable Registration Statement is declared effective by the Commission under all applicable state securities
or “blue sky” laws of such jurisdictions as Stifel or any Holder of Registrable Shares covered by a Registration Statement
shall reasonably request in writing, keep each such registration or qualification or exemption effective during the period such
Registration Statement is required to be kept effective pursuant to Section 4(a) and do any and all other acts and things
that may be reasonably necessary or advisable to enable such Holder to consummate the disposition in each such jurisdiction of
such Registrable Shares owned by such Holder; provided, however, that the Company shall not be required to (i) qualify
generally to do business in any jurisdiction or to register as a broker or dealer in such jurisdiction where it would not otherwise
be required to qualify but for this Section 4(d) and except as may be required by the Securities Act, (ii) subject itself
to taxation in any such jurisdiction or (iii) submit to the general service of process in any such jurisdiction;

 

(e) notify
Stifel and each Holder promptly and, if requested by Stifel or any Holder, confirm such advice in writing (i) when a Registration
Statement has become effective and when any post-effective amendments and supplements thereto become effective, (ii) of the
issuance by the Commission or any state securities authority of any stop order suspending the effectiveness of a Registration
Statement or the initiation of any Proceeding for that purpose, (iii) of any request by the Commission or any other federal,
state or foreign governmental authority for (A) amendments or supplements to a Registration Statement or related Prospectus
or (B) additional information, (iv) of the happening of any event during the period a Registration Statement is effective
as a result of which such Registration Statement or the related Prospectus or any document incorporated by reference therein contain
any untrue statement of a material fact or omits to state any material fact required to be stated therein or necessary to make
the statements therein, in the light of the circumstances under which they were made, not misleading (which information shall
be accompanied by an instruction to suspend the use of the Prospectus until the requisite changes have been made) and (v) at
the request of any such Holder, promptly to furnish to such Holder a reasonable number of copies of a supplement to or an amendment
of such Prospectus as may be necessary so that, as thereafter delivered to the purchaser of such securities, such Prospectus shall
not include an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary
to make the statements therein, in the light of the circumstances under which they were made, not misleading;

 

    10

     

    

 

(f) use
its commercially reasonable efforts to avoid the issuance of, or if issued, to obtain the withdrawal of, any order enjoining or
suspending the use or effectiveness of a Registration Statement or suspending the qualification of (or exemption from qualification
of) any of the Registrable Shares for sale in any jurisdiction, as promptly as practicable;

 

(g) upon
request, promptly furnish to each requesting Holder of Registrable Shares covered by a Registration Statement, without charge,
one conformed copy of such Registration Statement and any post-effective amendment or supplement thereto (without documents incorporated
therein by reference or exhibits thereto, unless requested);

 

(h) except
as provided in Section 5 hereof, upon the occurrence of any event contemplated by Section 4(e)(iv) hereof, use its commercially
reasonable efforts to promptly prepare a supplement or post-effective amendment to a Registration Statement or the related Prospectus
or any document incorporated therein by reference or file any other required document so that, as thereafter delivered to the
purchasers of the Registrable Shares, such Prospectus will not contain any untrue statement of a material fact or omit to state
a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under
which they were made, not misleading;

 

(i) if
requested by the representative of the underwriters, if any, or any Holders of Registrable Shares being sold in connection with
such offering, (i) promptly incorporate in a Prospectus supplement or post-effective amendment such information as the representative
of the underwriters, if any, or such Holders indicate relates to them or that they reasonably request be included therein and
(ii) make all required filings of such Prospectus supplement or such post-effective amendment as soon as reasonably practicable
after the Company has received notification of the matters to be incorporated in such Prospectus supplement or post-effective
amendment;

 

(j) in
the case of an Underwritten Offering, use its commercially reasonable efforts to furnish to the underwriters a signed counterpart,
addressed to the underwriters, of (i) an opinion of counsel for the Company, addressed to the underwriters, dated the date
of each closing under the underwriting agreement, reasonably satisfactory to the underwriters, and (ii) a “comfort”
letter, addressed to the underwriters and the Board of Directors, dated the effective date of such Registration Statement and
the date of each closing under the underwriting agreement, signed by the independent public accountants who have certified the
Company’s financial statements included in such Registration Statement, covering substantially the same matters with respect
to such Registration Statement (and the Prospectus included therein) and with respect to events subsequent to the date of such
financial statements, as are customarily covered in accountants’ letters delivered to underwriters in underwritten public
offerings of securities and such other financial matters as the underwriters may reasonably request;

 

(k) enter
into customary agreements (including in the case of an Underwritten Offering, an underwriting agreement in customary form and
reasonably satisfactory to the Company) and take all other reasonable action in connection therewith in order to expedite or facilitate
the distribution of the Registrable Shares included in such Registration Statement and, in the case of an Underwritten Offering,
make representations and warranties to the underwriters in such form and scope as are customarily made by issuers to underwriters
in underwritten offerings and confirm the same to the extent customary if and when requested;

 

(l) subject
to execution of such confidentiality agreements as may reasonably be requested by the Company, make available for inspection by
representatives of the Holders and the representative of any underwriters participating in any disposition pursuant to a Registration
Statement and any special counsel or accountants retained by such Holders or underwriters, all financial and other records, pertinent
corporate documents and properties of the Company and cause the respective officers, directors and employees of the Company to
supply all information reasonably requested by any such representatives, the representative of the underwriters, counsel thereto
or accountants in connection with a Registration Statement; provided, however, that the representatives of the Holders
and any underwriters will use commercially reasonable efforts, to the extent practicable, to coordinate the foregoing inspection
and information gathering and not materially disrupt the Company’s business operations;

 

(m) use
its commercially reasonable efforts (including, without limitation, seeking to cure any deficiencies cited by the exchange or
market in the Company’s listing or inclusion application) to list or include all Registrable Shares on a National Securities
Exchange;

 

    11

     

    

 

(n) prepare
and file in a timely manner all documents and reports required by the Exchange Act and, to the extent the Company’s obligation
to file such reports pursuant to Section 15(d) of the Exchange Act expires prior to the expiration of the effectiveness period
of the Registration Statement as required by Section 4(a) hereof, the Company shall register the Registrable Shares under
the Exchange Act and shall maintain such registration through the effectiveness period required by Section 4(a) hereof;

 

(o) provide
a CUSIP number for all Registrable Shares, not later than the effective date of the Registration Statement;

 

(p) (i)
otherwise use its commercially reasonable efforts to comply with all applicable rules and regulations of the Commission, (ii) make
generally available to its stockholders, as soon as reasonably practicable, earnings statements covering at least twelve (12) months
beginning after the effective date of the Registration Statement that satisfy the provisions of Section 11(a) of the Securities
Act and Rule 158 (or any similar rule promulgated under the Securities Act) thereunder, but in no event later than forty-five
(45) days after the end of each fiscal year of the Company, and (iii) not file any Registration Statement or Prospectus
or amendment or supplement to such Registration Statement or Prospectus to which any Holder of Registrable Shares covered by any
Registration Statement shall have reasonably objected on the grounds that such Registration Statement or Prospectus or amendment
or supplement does not comply in all material respects with the requirements of the Securities Act, each Holder having been furnished
with a copy thereof at least two (2) Business Days prior to the filing thereof;

 

(q) provide
and cause to be maintained a registrar and transfer agent for all Registrable Shares covered by any Registration Statement from
and after a date not later than the effective date of such Registration Statement;

 

(r) in
connection with any sale or transfer of the Registrable Shares (whether or not pursuant to a Registration Statement) that will
result in the securities being delivered no longer being Registrable Shares, cooperate with the Holders and the representative
of the underwriters, if any, to facilitate the timely preparation and delivery of certificates, if any, representing the Registrable
Shares to be sold, which certificates shall not bear any restrictive transfer legends (other than as required by the Company’s
organizational documents) and to enable such Registrable Shares to be in such denominations and registered in such names as the
representative of the underwriters, if any, or the Holders may request at least three (3) Business Days prior to any sale
of the Registrable Shares;

 

(s) in
connection with the initial filing of a Shelf Registration Statement and each amendment thereto with the Commission pursuant to
Section 2(a) hereof, cooperate with Stifel in connection with the filing with FINRA of all forms and information required
or requested by FINRA in order to obtain written confirmation from FINRA that FINRA does not object to the fairness and reasonableness
of the underwriting terms and arrangements (or any deemed underwriting terms and arrangements) relating to the resale of Registrable
Shares pursuant to the Shelf Registration Statement, including, without limitation, information provided to FINRA through its
Public Offering System, and pay all costs, fees and expenses incident to FINRA’s review of the Shelf Registration Statement
and the related underwriting terms and arrangements, including, without limitation, all filing fees associated with any filings
or submissions to FINRA and the reasonable legal expenses, filing fees and other disbursements of Stifel and any other FINRA member
that is the Holder of, or is affiliated or associated with an owner of, Registrable Shares included in the Shelf Registration
Statement (including in connection with any initial or subsequent member filing);

 

(t) in
connection with the initial filing of a Shelf Registration Statement and each amendment thereto with the Commission pursuant to
Section 2(a) hereof, provide to Stifel and its representatives the opportunity to conduct due diligence, including, without
limitation, an inquiry of the Company’s financial and other records, and make available members of its management for questions
regarding information which Stifel may request in order to fulfill any due diligence obligation on its part and, concurrent with
the initial filing of a Shelf Registration Statement with the Commission pursuant to Section 2(a) hereof;

 

(u) upon
effectiveness of the first Registration Statement filed under this Agreement, take such actions and make such filings as are necessary
to effect the registration of the Registrable Shares under the Exchange Act simultaneously with or immediately following the effectiveness
of the Registration Statement; and

 

    12

     

    

 

(v) in
the case of an Underwritten Offering, use its commercially reasonable efforts to cooperate and assist in any filings required
to be made with FINRA and in the performance of any due diligence investigation by any underwriter and its counsel (including
any “qualified independent underwriter,” if applicable) that is required to be retained in accordance with the rules
and regulations of FINRA.

 

The
Company may require the Holders to furnish (and each Holder shall furnish) to the Company such information regarding the proposed
distribution by such Holder of such Registrable Shares as the Company may from time to time reasonably request in writing or as
shall be required to effect the registration of the Registrable Shares, and no Holder shall be entitled to be named as a selling
stockholder in any Registration Statement and no Holder shall be entitled to use the Prospectus forming a part thereof if such
Holder does not provide such information to the Company. Any Holder that sells Registrable Shares pursuant to a Registration Statement
or as a selling security holder pursuant to an Underwritten Offering shall be required to be named as a selling stockholder in
the related Prospectus and to deliver a Prospectus to purchasers. Each Holder further agrees to furnish promptly to the Company
in writing all information required from time to time to make the information previously furnished by such Holder not misleading.

 

Each
Holder agrees that, upon receipt of any notice from the Company of the happening of any event of the kind described in Section 4(e)(ii),
4(e)(iii) or 4(e)(iv) hereof, such Holder will immediately discontinue disposition of Registrable Shares pursuant to a Registration
Statement until such Holder’s receipt of the copies of the supplemented or amended Prospectus. If so directed by the Company,
such Holder will deliver to the Company (at the expense of the Company) all copies in its possession, other than permanent file
copies then in such Holder’s possession, of the Prospectus covering such Registrable Shares current at the time of receipt
of such notice.

 

5. Black-Out
Period

 

(a) Subject
to the provisions of this Section 5 and a good faith determination by the Company that it is in the best interests of the
Company to suspend the use of the Registration Statement, following the effectiveness of a Registration Statement (and the filings
with any international, federal or state securities commissions), the Company, by written notice to Stifel and the Holders, may
direct the Holders to suspend sales of the Registrable Shares pursuant to a Registration Statement for such times as the Company
reasonably may determine is necessary and advisable (but in no event for more than an aggregate of ninety (90) days
in any rolling twelve (12) month period commencing on the Closing Date or more than sixty (60) days in any rolling ninety
(90) day period), if any of the following events shall occur: (i) the representative of the underwriters of an Underwritten
Offering of primary shares by the Company has advised the Company that the sale of Registrable Shares pursuant to the Registration
Statement would have a material adverse effect on a primary Underwritten Offering by the Company; (ii) the Company shall
have determined in good faith that (A) the offer or sale of any Registrable Shares would materially impede, delay or interfere
with any proposed financing, offer or sale of securities, acquisition, merger, tender offer, business combination, corporate reorganization
or other significant transaction involving the Company, (B) after the advice of counsel, the sale of Registrable Shares pursuant
to the Registration Statement would require disclosure of non-public material information not otherwise required to be disclosed
under applicable law and (C) (1) the Company has a bona fide business purpose for preserving the confidentiality of such
transaction, (2) disclosure would have a material adverse effect on the Company or the Company’s ability to consummate
such transaction or (3) renders the Company unable to comply with Commission requirements, in each case under circumstances
that would make it impractical or inadvisable to cause the Registration Statement (or such filings) to become effective or to
promptly amend or supplement the Registration Statement on a post-effective basis, as applicable; or (iii) the Company shall
have determined in good faith, after the advice of counsel, that it is required by law, rule or regulation or that it is in the
best interests of the Company to supplement the Registration Statement or file a post-effective amendment to the Registration
Statement in order to incorporate information into the Registration Statement for the purpose of (A) including in the Registration
Statement any prospectus required under Section 10(a)(3) of the Securities Act; (B) reflecting in the Prospectus included
in the Registration Statement any facts or events arising after the effective date of the Registration Statement (or of the most
recent post-effective amendment) that, individually or in the aggregate, represent a fundamental change in the information set
forth therein; or (C) including in the Prospectus included in the Registration Statement any material information with respect
to the plan of distribution not disclosed in the Registration Statement or any material change to such information. Upon the occurrence
of any such suspension, the Company shall use its best efforts to cause the Registration Statement to become effective or to promptly
amend or supplement the Registration Statement on a post-effective basis or to take such action as is necessary to make resumed
use of the Registration Statement compatible with the Company’s best interests, as applicable, so as to permit the Holders
to resume sales of the Registrable Shares as soon as possible.

 

    13

     

    

 

(b) In
the case of an event that causes the Company to suspend the use of a Registration Statement (a “Suspension Event”),
the Company shall give written notice (a “Suspension Notice”) to Stifel and the Holders to suspend sales of
the Registrable Shares and such notice shall state generally the basis for the notice and that such suspension shall continue
only for so long as the Suspension Event or its effect is continuing and the Company is using its best efforts and taking all
reasonable steps to terminate suspension of the use of the Registration Statement as promptly as possible. The Holders shall not
effect any sales of the Registrable Shares pursuant to such Registration Statement (or such filings) at any time after it has
received a Suspension Notice from the Company and prior to receipt of an End of Suspension Notice (as defined below). If so directed
by the Company, each Holder will deliver to the Company (at the expense of the Company) all copies other than permanent file copies
then in such Holder’s possession of the Prospectus covering the Registrable Shares at the time of receipt of the Suspension
Notice. The Holders may recommence effecting sales of the Registrable Shares pursuant to the Registration Statement (or such filings)
following further notice to such effect (an “End of Suspension Notice”) from the Company, which End of Suspension
Notice shall be given by the Company to the Holders and Stifel in the manner described above promptly following the conclusion
of any Suspension Event and its effect.

 

(c) Notwithstanding
any provision herein to the contrary, if the Company shall give a Suspension Notice pursuant to this Section 5, the Company
agrees that it shall extend the period of time during which the applicable Registration Statement shall be maintained effective
pursuant to this Agreement by the number of days during the period from the date of receipt by the Holders of the Suspension Notice
to and including the date of receipt by the Holders of the End of Suspension Notice and provide copies of the supplemented or
amended Prospectus necessary to resume sales.

 

6. Indemnification
and Contribution

 

(a) The
Company agrees to indemnify and hold harmless (i) each Holder of Preferred Stock or Registrable Shares and any underwriter
(as determined in the Securities Act) for such Holder (including, if applicable, Stifel), (ii) each Person, if any, who controls
(within the meaning of Section 15 of the Securities Act or Section 20(a) of the Exchange Act) any such Person described
in clause (i) (any of the Persons referred to in this clause (ii) being hereinafter referred to as a “Controlling
Person”) and (iii) the respective officers, directors, partners, members, employees, representatives and agents
of any such Person or any Controlling Person (any Person referred to in clause (i), (ii) or (iii) above may hereinafter
be referred to as a “Purchaser Indemnitee”), to the fullest extent lawful, from and against any and all losses,
claims, damages, judgments, actions, out-of-pocket expenses and other liabilities (the “Liabilities”), including
without limitation and as incurred, reimbursement of all reasonable costs of investigating, preparing, pursuing or defending any
claim or action, or any investigation or Proceeding by any governmental agency or body, commenced or threatened, including the
reasonable fees and expenses of counsel to any Purchaser Indemnitee, joint or several, directly or indirectly related to, based
upon, arising out of or in connection with, (A) with respect to any Registration Statement (or any amendment thereto), any
untrue statement or alleged untrue statement of a material fact contained therein or any omission or alleged omission to state
therein a material fact required to be stated therein or necessary to make the statement therein not misleading or (B) with
respect to any Prospectus (or any amendment or supplement thereto), Issuer Free Writing Prospectus (or any amendment or supplement
thereto), any preliminary Prospectus or any other document used to sell the Registrable Shares, any untrue statement or alleged
untrue statement of a material fact contained therein or any omission or alleged omission to state therein a material fact required
to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made,
not misleading, except insofar as such Liabilities arise out of or are based upon any untrue statement or omission or alleged
untrue statement or omission made in reliance upon and in conformity with information relating to any Purchaser Indemnitee furnished
to the Company, or any underwriter in writing by such Purchaser Indemnitee expressly for use therein. The Company shall notify
the Holders promptly of the institution, threat or assertion of any claim, Proceeding (including any governmental investigation),
or litigation of which it shall have become aware in connection with the matters addressed by this Agreement which involves the
Company or a Purchaser Indemnitee. The indemnity provided for herein shall remain in full force and effect regardless of any investigation
made by or on behalf of any Purchaser Indemnitee.

 

(b) In
connection with any Registration Statement in which a Holder of Registrable Shares is participating, and as a condition to such
participation, such Holder agrees, severally and not jointly, to indemnify and hold harmless the Company and each Person who controls
the Company within the meaning of Section 15 of the Securities Act or Section 20(a) of the Exchange Act and the respective
officers, directors, partners, members, employees, representatives and agents of such Person or Controlling Person to the same
extent as the foregoing indemnity from the Company to each Purchaser Indemnitee, but only with reference to untrue statements
or omissions or alleged untrue statements or omissions made in reliance upon and in conformity with information relating to such
Holder furnished to the Company in writing by such Holder expressly for use in such Registration Statement (or any amendment thereto),
Prospectus (or any amendment or supplement thereto), Issuer Free Writing Prospectus (or any amendment or supplement thereto) or
any preliminary Prospectus. Absent gross negligence or willful misconduct, the liability of any Holder pursuant to this paragraph
shall in no event exceed the net proceeds received by such Holder from sales of Registrable Shares pursuant to such Registration
Statement (or any amendment thereto), Prospectus (or any amendment or supplement thereto), Issuer Free Writing Prospectus (or
any amendment or supplement thereto) or any preliminary Prospectus.

 

    14

     

    

  

(c) If
any suit, action, Proceeding (including any governmental or regulatory investigation), claim or demand shall be brought or asserted
against any Person in respect of which indemnity may be sought pursuant to paragraph (a) or (b) above, such Person (the
“Indemnified Party”) shall promptly notify the Person against whom such indemnity may be sought (the “Indemnifying
Party”) in writing of the commencement thereof (but the failure to so notify an Indemnifying Party shall not relieve
it from any liability which it may have under this Section 6, except to the extent the Indemnifying Party is materially prejudiced
by the failure to give notice), and the Indemnifying Party, upon request of the Indemnified Party, shall retain counsel reasonably
satisfactory to the Indemnified Party to represent the Indemnified Party and any others the Indemnifying Party may reasonably
designate in such Proceeding and shall pay the reasonable fees and expenses actually incurred by such counsel related to such
Proceeding. Notwithstanding the foregoing, in any such Proceeding, any Indemnified Party shall have the right to retain its own
counsel, but the fees and expenses of such counsel shall be at the expense of such Indemnified Party, unless (i) the Indemnifying
Party and the Indemnified Party shall have mutually agreed in writing to the contrary, (ii) the Indemnifying Party failed
within a reasonable time after notice of commencement of the action to assume the defense and employ counsel reasonably satisfactory
to the Indemnified Party, (iii) the Indemnifying Party and its counsel do not actively and vigorously pursue the defense
of such action or (iv) the named parties to any such action (including any impleaded parties) include both such Indemnified
Party and Indemnifying Party, or any Affiliate of the Indemnifying Party, and such Indemnified Party shall have been reasonably
advised by counsel that, either (A) there may be one or more legal defenses available to it which are different from or additional
to those available to the Indemnifying Party or such Affiliate of the Indemnifying Party or (B) a conflict may exist between
such Indemnified Party and the Indemnifying Party or such Affiliate of the Indemnifying Party (in which case the Indemnifying
Party shall not have the right to assume nor direct the defense of such action on behalf of such Indemnified Party; it being understood,
however, that the Indemnifying Party shall not, in connection with any one such action or separate but substantially similar or
related actions in the same jurisdiction arising out of the same general allegations or circumstances, be liable for the fees
and expenses of more than one separate firm of attorneys (in addition to any local counsel) for all such Indemnified Parties,
which firm shall be designated in writing by those Indemnified Parties who sold a majority of the Registrable Shares sold by all
such Indemnified Parties and any such separate firm for the Company, the directors, the officers and such control Persons of the
Company as shall be designated in writing by the Company). The Indemnifying Party shall not be liable for any settlement of any
Proceeding effected without its written consent, which consent shall not be unreasonably withheld, but if settled with such consent
or if there is a final judgment for the plaintiff, the Indemnifying Party agrees to indemnify any Indemnified Party from and against
any loss or liability by reason of such settlement or judgment. No Indemnifying Party shall, without the prior written consent
of the Indemnified Party, effect any settlement of any pending or threatened Proceeding in respect of which any Indemnified Party
is or could have been a party and indemnity could have been sought hereunder by such Indemnified Party, unless such settlement
(i) includes an unconditional release of such Indemnified Party from all liability on claims that are the subject matter
of such Proceeding and (ii) does not include a statement as to or an admission of, fault, culpability or a failure to act
by or on behalf of the Indemnified Party.

 

(d) If
the indemnification provided for in paragraphs (a) and (b) of this Section 6 is for any reason held to be unavailable
to an Indemnified Party in respect of any Liabilities referred to therein (other than by reason of the exceptions provided therein)
or is insufficient to hold harmless a party indemnified thereunder, then each Indemnifying Party under such paragraphs, in lieu
of indemnifying such Indemnified Party thereunder, shall contribute to the amount paid or payable by such Indemnified Party as
a result of such Liabilities (i) in such proportion as is appropriate to reflect the relative benefits of the Indemnified
Party, on the one hand, and the Indemnifying Party(ies), on the other hand, in connection with the statements or omissions that
resulted in such Liabilities or (ii) if the allocation provided by clause (i) above is not permitted by applicable law,
in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) above but also the
relative fault of the Indemnifying Party(ies) and the Indemnified Party, as well as any other relevant equitable considerations.
The relative fault of the Company on the one hand and any Purchaser Indemnitees, on the other hand, shall be determined by reference
to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission
to state a material fact relates to information supplied by the Company or by such Purchaser Indemnitees and the parties’
relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission.

 

    15

     

    

 

(e) The
parties agree that it would not be just and equitable if contribution pursuant to this Section 6 were determined by pro
rata allocation (even if such Indemnified Parties were treated as one entity for such purpose), or by any other method of
allocation that does not take account of the equitable considerations referred to in Section 6(d) above. The amount paid
or payable by an Indemnified Party as a result of any Liabilities referred to in Section 6(d) above shall be deemed to include,
subject to the limitations set forth above, any reasonable legal or other expenses actually incurred by such Indemnified Party
in connection with investigating or defending any such action or claim. Notwithstanding the provisions of this Section 6,
in no event shall a Purchaser Indemnitee be required to contribute any amount in excess of the amount by which the net proceeds
received by such Purchaser Indemnitee from sales of Registrable Shares exceeds the amount of any damages that such Purchaser Indemnitee
has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. For purposes
of this Section 6, each Person, if any, who controls (within the meaning of Section 15 of the Securities Act or Section 20(a)
of the Exchange Act) Stifel or a Holder of Registrable Shares shall have the same rights to contribution as Stifel or such Holder,
as the case may be, and each Person, if any, who controls (within the meaning of Section 15 of the Securities Act or Section 20(a)
of the Exchange Act) the Company, and each officer, director, partner, employee, representative, agent or manager of the Company
shall have the same rights to contribution as the Company. Any party entitled to contribution will, promptly after receipt of
notice of commencement of any action, suit or Proceeding against such party in respect of which a claim for contribution may be
made against another party or parties, notify each party or parties from whom contribution may be sought, but the omission to
so notify such party or parties shall not relieve the party or parties from whom contribution may be sought from any obligation
it or they may have under this Section 6 or otherwise, except to the extent that any party is materially prejudiced by the
failure to give notice. No Person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities
Act) shall be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation.

 

(f) The
indemnity and contribution agreements contained in this Section 6 will be in addition to any liability which the Indemnifying
Parties may otherwise have to the Indemnified Parties referred to above. The Purchaser Indemnitee’s obligations to contribute
pursuant to this Section 6 are several in proportion to the respective number of Registrable Shares sold by each of the Purchaser
Indemnitees hereunder and not joint.

 

		7.	Market
                                         Stand-off Agreement

 

Each
Holder hereby agrees that it shall not, to the extent requested by the Company or an underwriter of securities of the Company,
directly or indirectly sell, offer to sell (including without limitation any short sale), grant any option or otherwise transfer
or dispose of any Preferred Stock, Registrable Shares or other Class A Common Stock or any securities convertible into or
exchangeable or exercisable for Class A Common Stock then owned by such Holder (other than to donees or partners of the Holder
who agree to be similarly bound) (a) in the case of the Company and each of its officers, directors, managers and employees,
in each case to the extent such person or entity holds or acquires and holds Registrable Shares, for a period beginning on the
effective date of, and continuing for one hundred eighty (180) days following the effective date of, the IPO Registration
Statement; (b) in the case of all other Holders who include Registrable Shares in the IPO Registration Statement, beginning
on the effective date of, and continuing for one hundred eighty (180) days following the effective date of the IPO Registration
Statement of the Company; and (c) in the case of all other Holders, who do not include Registrable Shares in the IPO Registration
Statement, for a period of sixty (60) days following the effective date of an IPO Registration Statement of the Company filed
under the Securities Act; provided, further, however, if (i) during the last seventeen (17) days of the applicable
restricted period, the Company issues an earnings release or material news or a material event relating to the Company occurs
or (ii) prior to the expiration of the applicable restricted period, the Company announces that it will release earnings
results during the sixteen (16) day period beginning on the last day of the applicable restricted period, then, in each case,
the restrictions imposed by this Agreement shall continue to apply until the expiration of the eighteen (18) day period beginning
on the issuance of the earnings release or the occurrence of the material news or event, unless the managing underwriter in the
Underwritten Offering waives, in writing, such extension or the Company is then an emerging growth company (as defined under the
Securities Act) and provided, however, that:

 

(a) the
restrictions above shall not apply to Registrable Shares sold pursuant to the IPO Registration Statement;

 

(b) all
executive officers and directors of the Company then holding Class A Common Stock or securities convertible into or exchangeable
or exercisable for Class A Common Stock enter into agreements that are no less restrictive;

 

    16

     

    

 

(c) the
Holders shall be allowed any concession or proportionate release allowed to any officer or director that entered into agreements
that are no less restrictive (with such proportion being determined by dividing the number of shares being released with respect
to such officer or director by the total number of issued and outstanding shares held by such officer or director); provided,
that nothing in this Section 7(c) shall be construed as a right to proportionate release for the executive officers and directors
of the Company upon the expiration of the period applicable to all Holders other than the executive officers and directors of
the Company; and

 

(d) this
Section 7 shall not be applicable if a Shelf Registration Statement of the Company filed under the Securities Act has been
declared effective prior to the filing of an IPO Registration Statement or the Registrable Securities were made eligible for trading
on the OTC QB or OTC QX prior to the filing of an IPO Registration Statement.

 

In
order to enforce the foregoing covenant, the Company shall have the right to place restrictive legends on the certificates representing
the securities as subject to this Section 7 and to impose stop transfer instructions with respect to the Registrable Shares
and such other securities of each Holder (and the securities of every other Person subject to the foregoing restriction) until
the end of such period. Notwithstanding anything to the contrary contained in this Agreement, nothing in this Section 7 shall
in any way limit any actions by Stifel, including the transfer or disposition of securities of the Company, in its capacity as
an underwriter, initial purchaser, placement agent or similar role with respect to the Company securities.

 

		8.	Termination
                                         of the Company’s Obligation

 

All
registration rights granted under this Agreement shall terminate and be of no further force or effect when there shall no longer
be any Registrable Securities outstanding.

 

		9.	Limitations
                                         on Subsequent Registration Rights

 

From
and after the date of this Agreement, the Company shall not, without the prior written consent of Holders beneficially owning
not less than a majority of the then outstanding Voting Shares (provided, however, that for purposes of this Section 9,
Voting Shares that are owned, directly or indirectly, by an Affiliate of the Company shall not be deemed to be outstanding) enter
into any agreement with any holder or prospective holder of any securities of the Company that would allow such holder or prospective
holder to (a) include such securities in any Registration Statement filed pursuant to the terms hereof, unless, under the
terms of such agreement, such holder or prospective holder may include such securities in any such registration only to the extent
that the inclusion of its securities will not reduce the amount of Registrable Shares of the Holders that is included or (b) have
its securities registered on a registration statement that could be declared effective prior to, or within 180 days of, the
effective date of any registration statement filed pursuant to this Agreement.

 

		10.	Miscellaneous

 

(a)
Remedies. In the event of a breach by the Company of any of its obligations under this Agreement, Stifel and each Holder,
in addition to being entitled to exercise all rights provided herein or, in the case of Stifel, in the Purchase/Placement Agreement,
or granted by law, including the rights granted in Section 2(g) hereof and recovery of damages, will be entitled to specific
performance of its rights under this Agreement. Subject to Section 6, the Company agrees that monetary damages would not
be adequate compensation for any loss incurred by reason of a breach by it of any of the provisions of this Agreement and hereby
further agrees that, in the event of any action for specific performance in respect of such breach, it shall waive the defense
that a remedy at law would be adequate.

 

(b)
Amendments and Waivers. The provisions of this Agreement, including the provisions of this sentence, may not be amended,
modified or supplemented, and waivers or consents to or departures from the provisions hereof may not be given, without the written
consent of the Company and Holders beneficially owning not less than two-thirds of the then outstanding Voting Shares; provided,
however, that for purposes of this Section 10(c), Preferred Stock and Registrable Shares that are owned, directly
or indirectly, by John S. Hendricks, any officer or director of the Company, or their respective Affiliates shall not be deemed
to be outstanding; provided, further, however, that any amendments, modifications or supplements to, or any waivers
or consents to departures from, the provisions of Section 7 hereof that would have the effect of extending the sixty (60) or
one hundred eighty (180) day periods referenced therein shall be approved by, and shall only be applicable to, those Holders
who provide written consent to such extension to the Company. No amendment shall be deemed effective unless it applies uniformly
to all Holders. Notwithstanding the foregoing, a waiver or consent to or departure from the provisions hereof with respect to
a matter that relates exclusively to the rights of a Holder whose securities are being sold pursuant to a Registration Statement
and that does not directly or indirectly affect, impair, limit or compromise the rights of other Holders may be given by such
Holder; provided that the provisions of this sentence may not be amended, modified or supplemented except in accordance
with the provisions of the first and second sentences of this paragraph.

 

    17

     

    

 

(c)
Notices. All notices and other communications, provided for or permitted hereunder, shall be made in writing and delivered
by facsimile (with receipt confirmed), overnight courier, registered or certified mail, return receipt requested, or by telegram:

 

(i) if
to a Holder, at the most current address given by the transfer agent and registrar of the Preferred Stock to the Company;

 

(ii) if
to the Company, at the offices of the Company at 8484 Georgia Ave., Suite 700, Silver Spring, Maryland 20910, Attention:
Tia Cudahy; and

 

(iii) if
to Stifel, at the offices of Stifel at One South Street, 17th Floor, Baltimore, Maryland 21202, Attention: Michael A.
Gilbert, Deputy General Counsel (facsimile (443) 224-1495).

 

(d)
Successors and Assigns. This Agreement shall inure to the benefit of and be binding upon the successors and assigns of
each of the parties hereto, including, without limitation and without the need for an express assignment or assumption, subsequent
Holders. The Company agrees that the Holders shall be third party beneficiaries to the agreements made hereunder by the Participants
and the Company, and each Holder shall have the right to enforce such agreements directly to the extent it deems such enforcement
necessary or advisable to protect its rights hereunder.

 

(e)
Counterparts. This Agreement may be executed in any number of counterparts and by the parties hereto in separate counterparts,
each of which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the
same agreement.

 

(f)
Headings. The headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect
the meaning hereof.

 

(g)
Governing Law. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF
NEW YORK, AS APPLIED TO CONTRACTS MADE AND PERFORMED WITHIN THE STATE OF NEW YORK, WITHOUT REGARD TO PRINCIPLES OF CONFLICTS OF
LAW. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY SUBMITS TO THE EXCLUSIVE JURISDICTION OF ANY STATE COURT IN THE STATE OF NEW
YORK OR ANY FEDERAL COURT SITTING IN NEW YORK IN RESPECT OF ANY SUIT, ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS
AGREEMENT, AND IRREVOCABLY ACCEPTS FOR ITSELF AND IN RESPECT OF ITS PROPERTY, GENERALLY AND UNCONDITIONALLY, THE JURISDICTION
OF THE AFORESAID COURTS. EACH OF THE PARTIES HERETO IRREVOCABLY WAIVES, TO THE FULLEST EXTENT IT MAY EFFECTIVELY DO SO UNDER APPLICABLE
LAW, ANY OBJECTION THAT IT MAY NOW OR HEREAFTER HAVE TO THE LAYING OF THE VENUE OF ANY SUCH SUIT, ACTION OR PROCEEDING BROUGHT
IN ANY SUCH COURT AND ANY CLAIM THAT ANY SUCH SUIT, ACTION OR PROCEEDING BROUGHT IN ANY SUCH COURT HAS BEEN BROUGHT IN AN INCONVENIENT
FORUM. THE PARTIES WAIVE THE RIGHT TO A TRIAL BY JURY IN ANY DISPUTE IN CONNECTION WITH THIS AGREEMENT.

 

(h)
Severability. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction
to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein
shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use
their commercially reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result
as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention
of the parties hereto that they would have executed the remaining terms, provisions, covenants and restrictions without including
any of such that may be hereafter declared invalid, illegal, void or unenforceable.

 

(i)
Entire Agreement. This Agreement, together with the Purchase/Placement Agreement, is intended by the parties hereto as
a final expression of their agreement, and is intended to be a complete and exclusive statement of the agreement and understanding
of the parties hereto in respect of the subject matter contained herein and therein.

 

    18

     

    

 

(j)
Registrable Shares Held by the Company or its Affiliates. Whenever the consent or approval of Holders of a specified percentage
of Preferred Stock and/or Registrable Shares is required hereunder, Preferred Stock and Registrable Shares held by the Company
or its Affiliates shall not be counted in determining whether such consent or approval was given by the Holders of such required
percentage.

 

(k)
Adjustment for Stock Splits, etc. Wherever in this Agreement there is a reference to a specific number of shares, then
upon the occurrence of any subdivision, combination or stock dividend of such shares, the specific number of shares so referenced
in this Agreement shall automatically be proportionally adjusted to reflect the effect on the outstanding shares of such class
or series of stock by such subdivision, combination or stock dividend.

 

(l)
Survival. This Agreement is intended to survive the consummation of the transactions contemplated by the Purchase/Placement
Agreement. The indemnification and contribution obligations under Section 6 of this Agreement shall survive the termination
of the Company’s obligations under Section 2 of this Agreement.

 

(m)
Attorneys’ Fees. In any action or Proceeding brought to enforce any provision of this Agreement, or where any provision
hereof is validly asserted as a defense, the prevailing party, as determined by the court, shall be entitled to recover its reasonable
attorneys’ fees in addition to any other available remedy.

 

(n)
Information. The Company will use commercially reasonable efforts to ensure that a Holder may access information, that
will be as current as reasonably practicable for the Company, regarding the number of such Registrable Shares held by, issuable
to, and issued to such Holder (the “Information”); provided, that the Company will retain full discretion regarding
timing and any delay for releasing such Information to such Holder. The Company will ensure that any such Holder of such Registrable
Shares will be capable of obtaining certification of Information pertaining to such Holder’s beneficial ownership of Registrable
Shares upon written request by such Holder to the Company or by other means as shall be specified by the Company in its sole discretion.
The Company may contract with one or more third-party service providers to provide Information and services referenced in this
paragraph and will retain full discretion in determining the nature of and technical details with respect to the Company’s
provision of Information and services referenced in this paragraph.

 

[Signature
page follows]

 

    19

     

    

 

IN
WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first above written.

 

	

         
	CURIOSITYSTREAM INC.
	 	 
	 	By:	/s/
                                         Clint Stinchcomb

	 	 	Name:	Clint
    Stinchcomb
	 	 	Title:	Chief
    Executive Officer
	 	 	 	 
	 	STIFEL,
    NICOLAUS & COMPANY, INCORPORATED
	 	 
	 	By:	/s/
                                         David Toepel

	 	 	Name:	David
    Toepel
	 	 	Title:	Managing
    Director

 

[Signature
Page to Registration Rights Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00315-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00315-of-00352.parquet"}]]